granisetron has been researched along with Nausea in 382 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (1.05) | 18.7374 |
| 1990's | 188 (49.21) | 18.2507 |
| 2000's | 83 (21.73) | 29.6817 |
| 2010's | 87 (22.77) | 24.3611 |
| 2020's | 20 (5.24) | 2.80 |
| Authors | Studies |
|---|---|
| Hiraki, Y; Hori, M; Kawanaka, H; Matsuo, N; Miyashita, H; Miyoshi, T; Odawara, M | 1 |
| Eom, YA; Jin, JY; Kang, JH; Kim, HK; Ko, YH; Park, SY; Sun, S; Woo, IS | 1 |
| Araki, T; Nagamine, A; Obayashi, K; Ohshima, S; Takahashi, E; Takahashi, Y; Uchiyama, C; Yamamoto, K; Yashima, H | 1 |
| Bao, Y; Li, X; Xu, K; Xu, X; Zhang, Z; Zhao, N | 1 |
| Abd-ElGawad, M; Abdelhay, HM; Abdelmonem, H; Abdelwadoud, GT; Ahmed, AE; Al-Dardery, NM; Alhosini, ANM; Kamel, MA; Mohamed, SW | 1 |
| Amano, Y; Hamaguchi, M; Hamaguchi, S; Hotta, T; Isobe, T; Itakura, M; Kuraki, T; Miura, K; Nakao, M; Okimoto, T; Tsubata, Y | 1 |
| Cabanillas Stanchi, KM; Döring, M; Ebinger, M; Feucht, J; Handgretinger, R; Hartmann, U; Koch, MS; Lang, P; Lange, V; Malaval, C; Mezger, M; Michaelis, S; Ost, M; Queudeville, M; Schober, S; Weber, S | 1 |
| Abe, M; Arai, T; Fujita, Y; Hayasaki, Y; Iihara, H; Kado, N; Mori, M; Morishige, KI; Murase, S; Nakamura, K; Sakurai, M; Shimaoka, R; Shimokawa, M; Suzuki, A; Takenaka, M; Yamamoto, S | 1 |
| Burckart, G; Garimella, N; Griebel, D; Heinrichs, MT; Kim, I; Krudys, K; Kumar, S; Mehrotra, N; Momper, JD; Mulberg, AE; Mulugeta, Y; Nelson, R; Reaman, G; Sachs, H; Sinha, V; Yao, L; Zineh, I | 1 |
| Cabanillas Stanchi, KM; Döring, M; Flaadt, T; Handgretinger, R; Lang, P; Michaelis, S; Rupprecht, JV; Schlegel, P; Vek, J; Weber, S | 1 |
| Aogi, K; Baba, M; Chiba, Y; Fujiwara, K; Hirano, G; Imamura, CK; Imoto, S; Matsumoto, K; Matsuura, K; Miyazaki, C; Naito, Y; Osaki, A; Saeki, T; Sato, K; Takahashi, M; Takano, T; Tamura, K; Tokunaga, S; Yanagihara, K | 1 |
| Armbruster, SD; Coleman, RL; Eifel, PJ; Fellman, BM; Frumovitz, M; Jhingran, A; Klopp, AH; Ramondetta, LM | 1 |
| Ebrahimi, M; Mehrzad, V; Moghaddas, A | 1 |
| Chua, AV; Hernandez, ARB; Real, IO | 1 |
| Carroll, E; Gamble, M; Glode, AE; Wright, GC | 1 |
| Console, G; Ferreri, A; Gentile, M; Gori, M; Loteta, B; Martino, M; Morabito, A; Moscato, T; Naso, V; Paviglianiti, A; Pitino, AL; Porto, G; Provenzano, PF; Rossi, M; Tripepi, G | 1 |
| Chuma, M; Goda, M; Hamada, Y; Hamano, H; Hayama, T; Horinouchi, Y; Ikeda, Y; Imai, T; Ishida, S; Ishizawa, K; Kirino, Y; Mitsuhashi, C; Nakamura, T; Niimura, T; Okada, N; Sakamoto, K; Shinomiya, K; Suzuki, Y; Takechi, K; Tsujinaka, K; Yagi, K; Yanagawa, H; Zamami, Y | 1 |
| Arai, T; Fujita, Y; Funaguchi, N; Gomyo, T; Hakamata, J; Hirose, C; Iihara, H; Ikemura, S; Imai, H; Kaito, D; Kawazoe, H; Kotake, M; Minato, K; Ohno, Y; Okura, H; Sakai, C; Shimokawa, M; Suzuki, A | 1 |
| A El-Azab, G; A Mahrous, M; A Tawfik, H | 1 |
| Aizawa, F; Chuma, M; Goda, M; Hamano, H; Ishizawa, K; Izawa-Ishizawa, Y; Kanda, M; Murai, Y; Niimura, T; Okada, N; Yagi, K; Yoshida, A; Yoshioka, T; Zamami, Y | 1 |
| Chen, CY; Hsu, CY; Hsu, YC; Tam, KW | 1 |
| Chen, YX; Chen, ZD; Cheng, Y; Dang, CX; Dong, J; Han, BH; Hu, B; Li, BL; Li, JL; Liu, B; Lu, JG; Qin, SK; Shi, JH; Shu, YQ; Sun, XC; Wang, D; Wang, HB; Wang, KM; Wang, QM; Wu, Q; Yang, LQ; Zhang, HL; Zhang, QY; Zhang, ZH | 1 |
| Yang, Y; Zhang, L | 1 |
| Bernhardt, MB | 1 |
| Doggrell, SA | 1 |
| Iida, H; Kojima, Y; Matsumoto, S; Miyazawa, K; Nagai, H; Nakamura, A | 1 |
| Akashi, K; Kadoyama, K; Kamezaki, K; Kato, K; Miyamoto, T; Mori, Y; Nakamura, T; Shiratsuchi, M; Takenaka, K; Uchida, M | 1 |
| Nyktari, V; Papaioannou, A; Spartinou, A | 1 |
| Ayuhara, H; Hama, T; Hayashi, T; Hirai, K; Inoue, K; Itoh, K; Kawasaki, Y; Kogure, Y; Nakao, M; Nishio, M; Shibata, K; Suzuki, K; Takeda, K; Tsuji, D; Yokoi, M | 1 |
| Bai, D; Du, Y; Gao, Y; He, S; Jiang, Z; Lu, D; Wang, F; Wang, N; Wang, Z; Zhu, S | 1 |
| Boccia, R; Calcanes, G; Caruana, D; McBride, A; Mosier, M; Vacirca, J | 1 |
| Akashi, K; Hosohata, K; Ikesue, H; Kato, K; Makihara, Y; Miyamoto, T; Mori, Y; Nakamura, T; Shiratsuchi, M; Suetsugu, K; Uchida, M | 1 |
| Akashi, K; Ariyama, H; Baba, E; Esaki, T; Hirano, G; Inadomi, K; Ito, M; Kumagai, H; Kusaba, H; Makiyama, A; Makiyama, C; Mitsugi, K; Nio, K; Shibata, Y; Shirakawa, T; Takayoshi, K; Tamura, S; Yamanaka, T | 1 |
| Goldman, RD; Hasegawa, D; Kishimoto, K; Kosaka, Y; Ono, A | 1 |
| Goto, K; Hama, T; Hashimoto, H; Itoh, K; Kawasaki, Y; Matsui, R; Seki, N; Suzuki, K; Tsuji, D; Yamamoto, N; Yamanaka, T | 1 |
| Erickson, R; Mosier, MC; Nebughr, N; Nibley, W | 1 |
| Gennari, A; Rondonotti, D | 1 |
| Abe, M; Fujita, Y; Hayasaki, Y; Iihara, H; Matsuoka, R; Morishige, K; Nagasawa, Y; Sakurai, M; Shimokawa, M; Suzuki, A | 1 |
| Araz, M; Artac, M; Beypinar, I; Inci, F; Karaagac, M; Koral, L; Korkmaz, L; Uysal, M | 1 |
| Piccioni, AL | 1 |
| Binder, G; Botteman, M; Corman, S; Nickel, K; Turini, M | 1 |
| Iwase, O; Nakajima, A; Nakamura, H; Okuyama, K; Yamada, Y; Yokoyama, H; Yoshimoto, K | 1 |
| Abdul Kassim, MS; Keat, CH; Phua, G; Poh, WK; Sriraman, M | 1 |
| Akashi, K; Egashira, N; Hiraiwa, H; Ichinose, K; Ikesue, H; Iwasaki, H; Kato, K; Miyamoto, T; Muta, T; Oishi, R; Sakurai, A; Shiratsuchi, M; Suetsugu, K; Takenaka, K; Teshima, T; Uchida, M | 1 |
| Akashi, K; Egashira, N; Hiraiwa, H; Ichinose, K; Ikesue, H; Iwasaki, H; Kato, K; Miyamoto, T; Muta, T; Nagata, K; Oishi, R; Sakurai, A; Shiratsuchi, M; Suetsugu, K; Takenaka, K; Teshima, T; Uchida, M | 1 |
| Goto, H; Myojo, T; Osawa, H | 1 |
| Iwata, N; Kishi, T; Matsuda, Y; Mukai, T | 1 |
| Ballinari, G; Barbour, SY; Cox, D; Morrow, GR; Schwartzberg, L; Thorn, MD | 1 |
| Akasaka, J; Furukawa, N; Kawaguchi, R; Kobayashi, H; Nagai, A; Sasaki, Y; Shigemitsu, A | 1 |
| Hashimoto, H; Murakami, M; Senba, S; Siraishi, T; Yamaguchi, I; Yamaguchi, K | 1 |
| Billio, A; Clarke, MJ; Morello, E | 2 |
| Kenjo, M; Kurisu, K; Nakamura, K; Nosaka, R; Saito, T; Sugiyama, K; Takayasu, T; Tominaga, A; Watanabe, Y; Yamasaki, F | 1 |
| Ghani, NA; Keat, CH | 1 |
| Iwase, O; Nakajima, A; Nakamura, H; Okuyama, K; Takayanagi, R; Yamada, Y; Yokoyama, H; Yoshimoto, K | 1 |
| Parkman, HP; Simmons, K | 1 |
| Asano, K; Ito, Y; Kim, S; Ogura, Y; Tasaka, A; Yamamoto, K; Yamatodani, A | 1 |
| Boccia, R; Cooper, W; Gabrail, N; Gralla, RJ; O'Boyle, E; Raftopoulos, H | 1 |
| Brygger, L; Herrstedt, J | 1 |
| Burhenne, J; Egerer, G; Freiberger, A; Goldschmidt, H; Gronkowski, M; Ho, AD; Hüsing, J; Mikus, G; Neben, K; Pelzl, le H; Schmitt, T; Thalheimer, M | 1 |
| Ahn, JS; Hong, YS; Kim, JE; Kim, KP; Kim, TW; Lee, J; Lee, JL; Park, SJ; Park, YS; Shin, DB; Sym, SJ | 1 |
| Ishimaru, K; Kaneko, K; Katsura, M; Takahashi, H; Takano, A; Yamaguchi, N | 1 |
| Aoki, Y; Hayashi, K; Higuchi, T; Igarashi, K; Inatani, H; Kato, T; Kimura, H; Nishida, H; Shimozaki, S; Shirai, T; Takeuchi, A; Tanzawa, Y; Tsuchiya, H; Yamamoto, N | 1 |
| Chow, E; DeAngelis, C; Hunyh, L; McDonald, R; Pasetka, M; Raman, S; Rowbottom, L | 1 |
| Doi, A; Hirayama, M; Kitayama, H; Kondo, T; Sugiyama, J; Tsuji, Y | 1 |
| Ahmed, S; Badawi, AA; El-Nabarawi, MA; El-Setouhy, DA; Sallam, N | 1 |
| Horita, H; Hotta, H; Kato, R; Kitamura, H; Kunishima, Y; Masumori, N; Takahashi, A; Takei, F | 1 |
| Ishida, T; Isogai, Y; Kato, N; Kuroda, T; Yamamoto, K; Yamatodani, A | 1 |
| Fujiwara, S; Kanemura, M; Ohmichi, M; Sasaki, H; Terai, Y; Tsunetoh, S | 1 |
| Baek, JH; Choi, YJ; Chung, JS; Joo, YD; Kim, HJ; Kim, YS; Koh, SJ; Lee, EM; Lee, HG; Lee, WS; Oh, SY; Seol, YM; Yun, EY | 1 |
| Boccia, R; Cooper, W; Gralla, RJ; O'Boyle, E; Raftopoulos, H | 1 |
| Fujimura, T; Fushida, S; Kadoya, N; Kaji, M; Kinami, S; Kinoshita, J; Nezuka, H; Ohta, T; Ohyama, S; Oyama, K; Takai, Y; Takeda, T; Tsuji, K; Tsukada, T; Tsukioka, Y; Yabushita, K | 1 |
| Arora, S; Chasen, M; Navari, R; Powers, D; Rapoport, B; Schnadig, I; Schwartzberg, L | 1 |
| Cui, Y; Hayashinaka, E; Katayama, Y; Nakaoka, T; Okauchi, T; Onoe, K; Shingaki, T; Takashima, T; Wada, Y; Watanabe, Y | 1 |
| Agajanian, R; Cooper, W; Dakhil, C; Gabrail, NY; Klepper, MJ; Mosier, MC; Payne, JY; Schnadig, ID; Schwartzberg, LS; Smith, RE; Taylor, C; Vacirca, JL; Wilks, ST | 1 |
| Hou, F; Le, Q; Li, H; Li, W; Liu, S; Shi, Q; Zheng, L; Zong, S | 1 |
| Hashizume, J; Higuchi, N; Kitahara, T; Kodama, Y; Matsunaga, N; Nakamura, T; Sakamoto, T; Sasaki, H; Sato, K; Yamaguchi, K | 1 |
| Aogi, K; Inoue, K; Kitagawa, C; Kubota, K; Ogura, T; Saito, M; Sakai, H; Sekine, I; Yanagita, Y; Yoshizawa, H | 1 |
| Coluzzi, F; Mattia, C | 1 |
| Asada, K; Enomoto, N; Fujisawa, T; Hayakawa, H; Imokawa, S; Inui, N; Karayama, M; Kuroishi, S; Masuda, M; Nakamura, Y; Suda, T; Suzuki, S; Toyoshima, M; Watanabe, H; Yamada, T; Yokomura, K | 1 |
| Azuma, M; Higuchi, K; Ishido, K; Katada, C; Koizumi, W; Sasaki, T; Tanabe, S; Wada, T; Yano, T | 1 |
| Du, Q; Xu, XL; Yu, B; Zhai, Q; Zhu, B | 1 |
| Arata, K; Azuma, K; Fujiwara, K; Goto, K; Hashimoto, H; Hayashi, T; Kogure, Y; Matsui, R; Nagase, S; Nakao, M; Nogami, N; Ohyanagi, F; Seki, N; Shimada, T; Shimada, Y; Suzuki, K; Takeda, K; Takiguchi, T; Yamamoto, N; Yamanaka, T | 1 |
| Deeks, ED | 1 |
| Bai, YX; Chen, YX; Chen, ZD; Cheng, Y; Han, BH; Li, YQ; Liu, JW; Liu, W; Ouyang, XN; Qin, SK; Shi, JH; Sun, XC; Wu, Q; Xu, JM; Yang, LQ; Yu, SY; Zhang, HL; Zhang, ZH | 1 |
| de Kam, ML; Derijk, RH; Jacobs, GE; Kamerling, IM; van Gerven, JM; van Pelt, J; Zitman, FG | 1 |
| Szántó, J; Tóth, J | 1 |
| Morrow, T | 1 |
| Aogi, K; Inoue, K; Kitagawa, C; Mitsuhashi, S; Ogura, T; Saito, M; Sakai, H; Sekine, I; Yanagita, Y; Yoshizawa, H | 1 |
| Adams, LM; Johnson, B; Kirby, LC; Lebowitz, P; Stoltz, R; Yue, L; Zhang, K | 1 |
| Drenth, HJ; Gill, D; Howell, J; Smeets, J | 1 |
| Fujiwara, Y; Hashimoto, H; Hojo, T; Kaneko, M; Kato, Y; Katsumata, N; Kobayashi, Y; Satake, S; Takashima, A; Takeuchi, M; Yamamoto, H; Yonemura, M | 1 |
| Du Bois, A | 1 |
| Horiuchi, C; Ishitoya, J; Katori, H; Kimura, M; Matsuda, H; Mikami, Y; Nagao, J; Sakuma, Y; Taguchi, T; Toth, G; Tsukuda, M; Yoshida, T | 1 |
| Curran, MP; Duggan, ST | 1 |
| Schulmeister, L | 1 |
| Chen, Q; Huang, C; Huang, J; Lin, T; Pan, L; Shen, H; Tian, W; Wang, J; Wang, Z; Zhang, L; Zhang, S; Zhou, J | 1 |
| Becze, E | 1 |
| Bi, F; Cao, D; Gou, HF; Hou, M; Jiang, M; Luo, de Y; Qiu, M; Shen, Y; Wang, J; Xu, F; Yang, Y; Yi, C; Zang, J; Zhou, XJ | 1 |
| Eguchi, K; Hoshi, E; Katsumata, N; Kawahara, M; Takagi, M; Takahashi, T | 1 |
| Boccia, RV; Clark, G; Gordan, LN; Grunberg, SM; Howell, JD | 1 |
| Behlendorf, T; Jahn, F; Jahn, P; Jordan, K; Kegel, T; Ruessel, J; Schmoll, HJ; Stein, A | 1 |
| Batu, ED; Büyükpamukçu, M; Civelek, E; Demir, HA; Saçkesen, C; Yalçın, B | 1 |
| Endo, M; Murakami, H; Nakamura, Y; Takahashi, T; Tsuya, A; Yamamoto, N | 1 |
| Hassan, BA; Yusoff, ZB | 1 |
| Daimon, T; Hashimoto, N; Ikematsu, Y; Kim, YI; Kimura, M; Maeda, M; Nakagaki, S; Taku, K; Tsubota, H; Tsuji, D | 1 |
| Hafiz, MG; Islam, A; Jamal, CY; Rokeya, B; Siddique, R | 1 |
| Abernethy, AP; Rangwala, F; Zafar, SY | 1 |
| Abolhasani, E; Hashemian, F; Panahi, Y; Saadat, A; Sahebkar, A; Taghikhani, M | 1 |
| Hori, K; Kawakami, J; Motohashi, S; Ohnishi, K; Ono, T | 1 |
| Curran, MP; Duggan, ST; Keating, GM | 1 |
| Goto, T; Ishibashi, M; Okamura, S; Tanimoto, K | 1 |
| Dakhil, SR; Heckler, CE; Kuebler, JP; Mohile, SG; Morrow, GR; Roscoe, JA; Wade, JL | 1 |
| Eguchi, K; Katakami, N; Katsumata, N; Kawahara, M; Saito, H; Yoshimori, K; Yoshizawa, H | 1 |
| Eksborg, S; Lönnqvist, PA; Öbrink, E; Oddby-Muhrbeck, E; Rotstein, S | 1 |
| Fujimura, T; Fushida, S; Hirono, Y; Hirosawa, H; Kaji, M; Kimura, H; Kinami, S; Kinoshita, J; Nakano, T; Ohta, T; Oyama, K; Takai, Y; Takeda, T; Tsukada, T; Tsuneda, A; Yabushita, K; Yasui, T; Yoshimoto, K | 1 |
| Akashi, K; Egashira, N; Hiraiwa, H; Ichinose, K; Ikesue, H; Iwasaki, H; Kato, K; Miyamoto, T; Oishi, R; Sakurai, A; Takenaka, K; Teshima, T; Uchida, M | 1 |
| Markman, M | 1 |
| Cooper, M; Smith, J; Sologuren, A; Valiente, R | 1 |
| Fukunaka, N; Ishioka, S; Kobayashi, K; Kudo, R; Minami, M; Nishioka, Y; Sagae, S; Sugimura, M; Terasawa, K | 1 |
| Chen, Y; Cheng, G; Feng, F; He, Y; Li, Y; Zhang, P; Zhou, M | 1 |
| Leelasiri, A; Mongkonsritragoon, W; Numbenjapon, T; Prayoonwiwat, W; Sriswasdi, C | 1 |
| Fujii, Y; Tanaka, H | 1 |
| Minami, M | 1 |
| Steiner, MA; Theisen, J; Vermeulen, LC; Yorgason, RZ | 1 |
| Fujii, Y; Kawasaki, T; Tanaka, H | 1 |
| Prentice, HG | 1 |
| Chen, G; Feng, F; He, Y; Li, L; Li, Y; Zhang, P; Zhou, M | 1 |
| Tan, M | 1 |
| Carmichael, J; Harris, AL | 1 |
| Liu, YP; Shi, J; Teng, YE; Zhang, JD | 1 |
| Coop, AJ; Dempsey, CL; Eberhardt, DR; Farley, PA; O'Briant, S; Shillington, A | 1 |
| Seth, R; Tan, M; Xu, R | 1 |
| Goldsmith, B | 1 |
| Bradshaw, P; Callander, N; Clark, G; Freytes, CO; Holle, LM; Morris, AK; Valley, AW; Walsh, T | 1 |
| Aapro, M | 1 |
| Bhatnagar, S; Dua, N; Mishra, S; Singhal, AK | 1 |
| Fibich, C; Grothey, A; Jordan, K; Kegel, T; Schöbert, C | 1 |
| Barni, S; Cabiddu, M; Cazzaniga, M; Cremonesi, M; Di Cosimo, S; Ferretti, G; Ghilardi, M; Mandalà, M; Rocca, A | 1 |
| Buyukavci, M; Ceviz, N; Olgun, H | 1 |
| del Giglio, A; Moreno, J; Sahade, M | 1 |
| Hamada, J; Kai, Y; Kochi, M; Kuratsu, J; Makino, K; Morioka, M; Nakamura, H; Yano, S | 1 |
| Feyer, P; Seegenschmiedt, MH; Steingraeber, M | 1 |
| Fukunaga, H; Ikeda, M; Ikenaga, M; Monden, M; Ohue, M; Sekimoto, M; Seshimo, I; Takayama, O; Yamamoto, H; Yasui, M | 1 |
| Barr, J; Heller, J | 1 |
| Aapro, M; Rabaeus, M | 1 |
| Acar, S; Baysal, K; Dagdemir, A; Elli, M; Pinarli, FG | 1 |
| Changkuingdee, N; Cheirsilpa, A; Chulaka, K; Sinthusake, T; Songsakkaesorn, A; Visawaprasit, S | 1 |
| Abali, H; Aynacioglu, AS; Babaoglu, MO; Bayar, B; Bozkurt, A; Celik, I; Kerb, R | 1 |
| Endo, K; Inoue, S; Itou, H; Nakamura, R | 1 |
| Caran, EM; Luisi, FA; Petrilli, AS; Tanaka, C | 1 |
| del Giglio, A; Lajolo, PP | 1 |
| Awab, A; Chaudhary, L; Hamadani, M; Tfayli, A | 1 |
| Hashimoto, R; Ikeda, K; Kurokawa, N; Okamoto, Y; Takagi, T; Takenaka, M; Ueda, T; Uejima, E | 1 |
| Herrstedt, J | 1 |
| Bakirci, N; Beker, B; Berrak, SG; Canpolat, C; Ozdemir, N; Turkkan, E; Yoruk, A | 1 |
| Wilkes, G | 1 |
| Awan, FT; Chaudhary, L; Hamadani, M; Khan, JK; Kojouri, K; Ozer, H; Tfayli, A | 1 |
| Vrabel, M | 1 |
| Buchanan, D; Muirhead, K | 1 |
| Awata, H; Hashimoto, Y; Katayama, M; Kitagawa, J; Kodama, Y; Miyata, Y; Nakade, S; Ohno, T | 1 |
| Iwase, O; Okuyama, K; Ozeki, T; Yamada, Y; Yoshimoto, K | 1 |
| Enomoto, H; Furukawa, M; Furukawa, S; Kokatsu, T; Kubota, A; Tsukuda, M | 1 |
| Imahori, T; Kasai, H; Kawamoto, K; Numa, Y; Tsuchida, T | 1 |
| McTavish, D; Yarker, YE | 1 |
| Perez, EA | 1 |
| Becker, A; Debrix, I; Milleron, B; Puteaux, S | 1 |
| Futatsugi, K; Kobayashi, H; Koizumi, W; Komatsu, H; Minato, K; Nakarai, I; Nukariya, N; Taira, O; Uchiyama, T; Yamaguchi, T | 1 |
| Nodoushani, M | 1 |
| Fujii, Y; Tanaka, H; Toyooka, H | 18 |
| Blower, P; Grélot, L; Milano, S; Romain, D | 1 |
| Bremer, K; Cupissol, D; Dilly, SG; Goedhals, L; Noble, A | 1 |
| Enomoto, H; Furukawa, M; Ikema, Y; Kawai, S; Kohno, H; Kubota, A; Makino, Y; Matsuda, H; Tsukuda, M; Yago, T | 1 |
| Kagawa, T; Konishi, S; Moritake, K; Nagai, H; Nagao, S; Yamasaki, T | 1 |
| Hayashida, S; Hirasawa, T; Mitsui, H; Nasu, T; Shinohara, Y; Uchiyama, K | 1 |
| Maekawa, N; Mikawa, K; Nishina, K; Obara, H; Takao, Y | 1 |
| Fitts, D; Friedman, C; Gandara, D; Hall, S; Hesketh, P; Mailliard, J; Navari, R; Ritter, H | 1 |
| Kattlove, H | 1 |
| Arioka, H; Eguchi, K; Karato, A; Kunikane, H; Nakashima, H; Nisio, M; Ohe, Y; Ohmatsu, H; Shinkai, T; Tamura, T | 1 |
| Böhm, S; Bresciani, G; Oriana, S | 1 |
| Eguchi, F; Emoto, M; Hachisuga, T; Kawarabayashi, T; Mohtai, H; Shindo, M; Shirakawa, K | 1 |
| Campana, F; Cosset, JM; Feuvret, L; Fourquet, A; Jammet, P | 1 |
| Fitts, D; Gralla, RJ; Grunberg, SM; Kaplan, HG; Navari, RM; Palmer, R | 1 |
| Kawashima, T; Matsuhira, J; Morita, N; Okamoto, K; Sakamoto, T; Wada, T | 1 |
| Cedar, E; Cunningham, J; Goedhals, L; Heron, JF; Jordaan, JP | 1 |
| Blower, PR; Boyle, EA; Davey, PT; Marr, HE | 1 |
| Osoba, D; Pater, J; Rusthoven, J; Slamet, L; Warr, D; Zee, B | 1 |
| Soukop, M | 2 |
| Ang, PT; Khoo, KS; Tan, EH | 1 |
| Dilly, S | 2 |
| Gandara, DR; Perez, EA | 1 |
| Palmer, R | 1 |
| Eisenberg, PD | 1 |
| Hamada, T; Hayasaka, S; Ida, M; Kawano, S; Kuwahara, T; Matsumura, K; Nomura, H; Ueda, K; Ushijima, M; Yoshinaga, T | 1 |
| Hanaoka, J; Hataya, I; Kodama, S; Maruhashi, T; Takahashi, T; Takeuchi, Y; Tanaka, K; Tokunaga, A; Yanase, T; Yoshiya, N | 1 |
| Cannata, G; Cipolla, C; Curto, G; Gebbia, N; Gebbia, V; Latteri, MA; Testa, A; Valenza, R | 1 |
| Aapro, MS; Kirchner, V; Terrey, JP | 1 |
| Riviere, A | 1 |
| Enomoto, H; Furukawa, M; Furukawa, S; Kohno, H; Kokatsu, T; Kubota, A; Tsukuda, M | 1 |
| Kawashima, T; Miyata, K; Morita, N; Ohmata, T; Sakamoto, T; Wada, T | 1 |
| Fujimoto, T; Hirota, T; Honjo, T; Katano, N; Kuroda, R; Saeki, K; Sakakibara, Y; Shimizu, H | 2 |
| Ohta, J; Taguchi, T; Tsukagoshi, S | 1 |
| Daimaru, O; Fujimoto, T; Hirota, T; Kato, R; Koike, A; Kojima, T; Noda, A; Noguchi, M; Shimizu, H; Yabushita, H | 1 |
| Adenis, L; Allen, A; Bessell, E; Bressolle, F; Carmichael, J; Cupissol, D; Romain, D; Wargenau, M | 1 |
| Smith, IE | 2 |
| de Wet, M; Falkson, G; Rapoport, BL | 1 |
| Fukunaka, N; Ishioka, S; Itoh, E; Kitajima, Y; Kudo, R; Sagae, S; Sato, K | 1 |
| Chevallier, B | 1 |
| Furue, H; Niitani, H; Ogawa, N; Ohta, K; Suminaga, M; Taguchi, T | 2 |
| Gondo, H; Harada, M; Matsuishi, H; Omori, F; Otsuka, T; Shibuya, T; Taniguchi, S; Teshima, T; Yamano, Y; Yamazaki, K | 1 |
| Aapro, MS | 2 |
| Mori, K; Suga, Y; Takahashi, T; Tominaga, K | 1 |
| Hiraoka, A; Kageyama, T; Kakishita, E; Masaoka, T; Matsuzawa, Y; Nagai, K; Okuda, K; Oshiba, S; Tatsumi, N; Uchino, H | 1 |
| Kitada, M; Sawaragi, I | 1 |
| Akaza, H; Hattori, K; Hinotsu, S; Ishikawa, S; Iwasaki, A; Kikuchi, K; Koiso, K; Kondo, F; Manabe, F; Nishijima, Y; Noguchi, R; Otani, M; Sato, K; Shimazui, T; Uchida, K | 1 |
| Casey, PA; Terrey, JP | 1 |
| Bianchi, A; Curreli, L; Ghiani, M; Macciò, A; Mantovani, G; Proto, E; Santona, MC | 1 |
| Cannata, G; Gebbia, N; Gebbia, V; Testa, A; Tirrito, ML; Valenza, R | 1 |
| Hickok, JT; Morrow, GR; Rosenthal, SN | 1 |
| Collini, D; Fedele, P; Lucia, C; Manicone, M; Spina, M; Tirelli, U; Valentini, M | 1 |
| Eisenberg, PD; Ettinger, DS; Fitts, D; Friedman, C; Wilson-Lynch, K; Yocom, K | 1 |
| Diemunsch, P; Helbo-Hansen, HS; Kong, KL; Kroeks, MV; Lindeque, BG; Scheinin, H; Wilson, AJ | 1 |
| Akazawa, S; Inai, T; Kagawa, S; Kanayama, H; Naruo, S; Ogawa, I; Sakurai, N; Sumitani, H; Takigawa, H; Yokoseki, H | 1 |
| Angelelli, B; Guaraldi, M; Martoni, A; Pannuti, F; Strocchi, E | 1 |
| Alon, E; Biro, P | 1 |
| Parasuraman, TV; Paska, W; Thwaites, R | 1 |
| Bonneterre, J; Hecquet, B | 1 |
| Fujishima, H; Hisano, C; Masumoto, N; Nakamura, M; Nakano, S; Niho, Y; Okuma, K | 1 |
| Acito, L; Bascioni, R; De Signoribus, G; Giorgi, F; Giuliodori, L; Giustini, L; Marcellini, M; Menichetti, ET; Silva, RR | 1 |
| Attia, M; Channa, AB; el Bakry, AK; el Gammal, K; el Gammal, M; Elhattab, YS; Jaroudi, R; Khoshim, MH; Naguib, M; Saddique, A | 1 |
| King, RS; Krytzer, AC | 1 |
| Contu, A; Depenni, R; Donati, D; Maestri, A; Meriggi, F; Olmeo, N; Piro, S; Sabbatini, R; Silingardi, V; Zaniboni, A | 1 |
| Alberts, VA; Catalano, G; Poole, MA | 1 |
| Cieslak, GD; Pennant, JH; Phillips, MB; Watcha, MF | 1 |
| Teixeira, GM; Tremont-Lukats, IW | 1 |
| Fitts, D; Gralla, RJ; Grunberg, SM; Kaplan, HG; Navari, RM; Palmer, RH; Perez, EA | 1 |
| Kubo, Y; Kurita, A; Nakata, M; Ohsumi, S; Saeki, H; Saiki, T; Takashima, S; Takiyama, W; Tanada, M; Yokoyama, N | 1 |
| Aoyama, H; Babaya, K; Hayashi, Y; Hiramatsu, T; Hirao, YK; Kaneko, Y; Maruyama, Y; Matsuki, H; Momose, H; Natsume, O; Ohara, S; Okajima, E; Ozono, S; Sasaki, K; Shiomi, T; Tabata, S; Takashima, K; Watanabe, S; Yamada, K; Yoshikawa, M | 1 |
| Tsukagoshi, S | 1 |
| Aranda, E; Auclerc, G; Audhuy, B; Benhammouda, A; Bleiberg, H; Cals, L; Cappelaere, P; Cattan, A; Cervantes, A; Chevallier, B; Claverie, N; Conroy, T; Cupissol, D; De Grève, J; Diaz-Rubio, E; Fabbro, M; Faraldi, M; Khayat, D; Martin, M; Rivière, A; Seitz, JF | 1 |
| Hatano, Y; Kato, N; Okuyama, N; Park, Y; Sasamoto, S; Yamazaki, S | 1 |
| Chang, CS; Chen, LT; Chen, TP; Huang, SM; Lin, SF; Liu, TC; Wei, TC | 1 |
| Akutagawa, N; Fukunaka, N; Hayashi, T; Kitajima, Y; Kudo, R; Mizumoto, H; Nakamura, T; Sagae, S; Sugimura, M; Terasawa, K; Wataba, K; Yamana, K | 1 |
| Benline, TA; French, J | 1 |
| Fukuoka, M; Furue, H; Furuse, K; Kawahara, M; Kusunoki, Y; Negoro, S; Ogawara, M; Takada, M | 1 |
| Basurto, C; Ciccarese, G; Palladino, MA; Roila, F | 1 |
| Fujii, M; Imanishi, Y; Kanke, M; Kanzaki, J; Ohno, Y; Tokumaru, Y | 1 |
| Aoki, Y; Endo, M; Furue, H; Hanaoka, J; Honma, S; Kodama, S; Maruhashi, T; Oshima, T; Takahashi, T; Takeuchi, Y; Tanaka, K; Tokunaga, A; Yoshiya, N | 1 |
| Cunningham, RS | 1 |
| Saphir, A | 1 |
| Maekawa, N; Mikawa, K; Nishina, K; Obara, H; Shiga, M; Takao, Y | 1 |
| Bernstein, G; Colgan, K; Dempsey, CL; Farley, PA; Kulis-Robitaille, C; Shillington, AA | 1 |
| Aapro, M; Alberto, P; Kirchner, V; Terrey, JP | 1 |
| Chung, HC; Kim, BS; Kim, JH; Min, JS; Park, JO; Rha, SY; Roh, JK; Yoo, NC | 1 |
| Diemunsch, PA; Houweling, PL; Rosen, M; Taylor, AM; Thorin, D | 1 |
| Burish, T; Flynn, PJ; Hynes, HE; Morrow, GR; Pierce, HI; Roscoe, JA | 1 |
| Bushnell, W; Chawla, S; Friedman, C; Hainsworth, J; Hesketh, P; Markman, M; Perez, EA; Reeves, J; Sandbach, J | 1 |
| Baltzer, L; Berkery, R; Grossano, D; Kris, MG; Lucarelli, CD; Nolte, MJ; Pizzo, B | 1 |
| Goto, S; Hirabayashi, N; Horibe, K; Kato, Y; Kodera, Y; Kojima, H; Matsuyama, T; Morishima, Y; Morishita, Y; Nagata, K; Naoe, T; Ogura, M; Saito, H; Sao, H; Tanimoto, M; Utsumi, M; Yamada, H; Yano, K; Yazaki, M | 1 |
| Dhaliwal, H; Ernst, S; Findlay, B; Hoskins, P; Johnston, D; Laberge, F; Latreille, J; McMurtrie, E; Mee, D; Nishimura, L; Osoba, D; Pater, J; Rusthoven, J; Shepherd, F; Stewart, D; Walde, D; Warr, D; Williams, C; Yelle, L; Zee, B | 1 |
| Fitts, D; Friedman, C; Gralla, RJ; Hall, SW; Hand, L; Ritter, HL; Wada, JK | 1 |
| Fujii, Y; Saitoh, Y; Tanaka, H; Toyooka, H | 4 |
| Akashi, A; Ikeda, M; Kido, T; Minami, M; Nakahara, K; Nakamura, K; Ohta, M; Yasumitsu, T | 1 |
| Bushnell, W; Einhorn, L; Ettinger, D; Friedman, C; Gralla, RJ; Hesketh, PJ; Navari, RM; Noy, J; Popovic, W; Strupp, J | 1 |
| Fujii, H; Horiike, S; Iwai, T; Kaneko, H; Kashima, K; Misawa, S; Nakagawa, H; Nakao, M; Nakazawa, N; Ookawara, Y; Sasai, Y; Tamura, A; Taniwaki, M; Tsuda, S; Ueda, Y; Yokota, S | 1 |
| Agay, D; Fatôme, M; Martin, C; Roman, V | 1 |
| Beresneva, IA; Gershanovich, ML | 1 |
| Fujimori, R; Sanada, H; Sekine, M; Serikawa, T; Shichiri, K; Tanaka, K | 1 |
| Clarke, J | 1 |
| Aznar, E; Climent, MA; Guillem, V; Olmos, T; Palau, J; Ruiz, A; Soriano, V | 1 |
| Chow, LW; Poon, RT | 1 |
| Finley, RS; Stull, DM; Trovato, JA | 1 |
| Bolwell, B; Boparai, N; Jones, E; Kalaycio, M; Mendez, Z; Overmoyer, B; Pohlman, B | 1 |
| Burghouts, J; de Wit, R; Fonteyn, M; Keizer, J; Nortier, J; Rodenburg, C; Slee, P; van den Berg, H; Verweij, J; Wils, J | 1 |
| Carmichael, J; Cupissol, D; Keizer, HJ; Milliez, J; Scheidel, P; Schindler, AE | 1 |
| Goedhals, L; Heron, JF; Kleisbauer, JP; Pagani, O; Sessa, C | 1 |
| Ben Dayan, D; Ben Zion, T; Cohen, AM; Kaufman, O; Mittelman, M; Zeidman, A | 1 |
| Bleuse, JP; Block, S; Bonneterre, J; Bonneterre, ME; Carlier, D; Darloy, F; Fournier, C; Huc, P | 1 |
| Moriguchi, T; Tsudo, M | 1 |
| Asakura, H; Doya, Y; Hara, H; Hata, K; Hatakeyama, S; Hirose, S; Ichida, T; Isokawa, O; Itoh, S; Nozawa, A; Ohta, H; Takagi, K; Tsuruya, T; Watanabe, T | 1 |
| Ikeda, H; Koshiba, R | 1 |
| Birch, R; Buckner, CD; Carson, K; Weaver, CH | 1 |
| Hipple, TF; Morosco, RS; Nahata, MC | 1 |
| McQuay, HJ; Moore, RA; Reynolds, DJ; Stoner, NS; Tramèr, MR | 1 |
| Abbott, B; Bruton, J; Champlin, R; Ippoliti, C; Neumann, J; Whaley, R | 1 |
| Ancona, G; Brunetti, P; Calò, A; Mattioli, V; Pisoni, G; Zollino, D | 1 |
| Akaza, H; Hattori, K; Hinotsu, S; Ishikawa, S; Koiso, K; Kondo, F; Noguchi, R; Ohtani, M; Uchida, K | 1 |
| Masaoka, T; Tatsumi, N | 1 |
| Benfield, P; Plosker, GL | 1 |
| Bercez, C; Bonneterre, J | 1 |
| Fujii, Y; Kobayashi, N; Tanaka, H | 1 |
| Granisétron, PK; Mabro, M | 1 |
| Arthur, V; Devlin, J; Emery, P; Wagstaff, K | 1 |
| Andersen, LJ; Dombernowsky, P; Havsteen, H; Herrstedt, J; Kjaer, M; Kjaerbøl, AG; Langer, SW; Lund, H; Sigsgaard, T | 1 |
| Hirota, K; Kikuchi, H; Nakayama, T; Nasu, M; Ohno, E; Ohtuka, E; Ono, K; Saburi, Y; Uchida, I; Uno, N | 1 |
| Kaneko, M; Matsumura, T; Mugishima, H; Ohira, M; Onuma, N; Sakurai, M; Sawada, T; Sugimoto, T; Takeda, T | 1 |
| Perez, EA; Solberg, LA; Tiemeier, T | 1 |
| O'Sullivan, GC; Shanahan, F | 1 |
| Burns, L; DeFor, TE; Larson, H; Orchard, PJ; Ramsay, NK; Rogosheske, J; Rydholm, N; Weisdorf, D | 1 |
| Fujiwara, K; Ishikawa, H; Kohno, I; Nagaji, M; Suzuki, S; Yamauchi, H | 1 |
| Fujii, Y; Somekawa, Y; Tanaka, H | 1 |
| Edelman, M; Gandara, DR; Hesketh, AM; Hesketh, PJ; Perez, EA; Roman, A | 1 |
| Alkiş, N; Kartum, A; Oge, A; Oge, O | 1 |
| Breatnach, F; Cohn, R; Gentet, JC; Hahlen, K; Mabro, M; Madon, E; Margueritte, G; Zanesco, L | 1 |
| Andersen, O; Christensen, P; Dombernowsky, P; Herrstedt, J; Sigsgaard, T | 1 |
| Akutagawa, N; Ishioka, S; Ito, E; Kiya, T; Kudo, R; Sagae, S; Saito, T; Sugimura, M; Umemura, K | 1 |
| Blackburn, LM; Burris, HA; Friedman, CJ; Gruben, D; Yocom, K | 1 |
| Baron, PL; Cole, DJ; Maize, JC; McClay, EF; McClay, ME; Metcalf, JS; Monroe, L; O'Brien, PH | 1 |
| Bushnell, W; Frankel, SR; Friedman, CJ; Raschko, J; Spitzer, TR | 1 |
| Barrajon, E; de las Peñas, R | 1 |
| Fukazawa, S; Fukushima, T; Hosoi, H; Ichikawa, Y; Ike, H; Kubo, A; Kunisaki, C; Moriwaki, Y; Obi, Y; Oki, S; Shimada, H; Suda, T; Takahashi, M; Takahashi, T; Togo, S; Yamaguchi, S; Yamazaki, Y | 1 |
| Chen, PM; Chiou, TJ; Fan, FS; Liu, JH; Tzeng, WF; Wang, WS; Yen, CC | 1 |
| Herrington, JD; Kwan, P; Lagow, E; Lagrone, L; Riggs, MW; Young, RR | 1 |
| Klener, P; Procházka, B; Slabý, J; Trnený, M | 1 |
| Araújo Pereira, ME; Carmo, JA; Juncal, C; Lacerda, JF; Lacerda, JM; Lourenço, MF; Martins, C; Rodrigues, A | 1 |
| Caparroz, C; Castro, PC; del Giglio, A; Soares, HP | 1 |
| Brown, MB; Hasler, WL; Ladabaum, U; Owyang, C; Pan, W | 1 |
| Fujii, M; Imanishi, Y; Kanke, M; Kanzaki, J; Ohno, Y; Tokumaru, Y; Tomita, T | 1 |
| Nakayama, S; Noda, T; Torii, Y | 1 |
| Akman, SA; Aksoylar, S; Kansoy, S; Ozgenç, F | 1 |
| Fisher, SG; Fletcher-Gonzalez, D; Fox-Geiman, MP; Kiley, K; Porter, N; Stiff, P | 1 |
| Dranitsaris, G; Leung, P; Warr, D | 1 |
| Friedman, C; Lanciano, R; Michalski, J; Preston, AJ; Sherman, DM; Yocom, K | 1 |
| Feng, F; He, Y; Zhang, P | 1 |
| Cui, C; Wang, J; Yang, L | 1 |
| Allgar, V; Goss, I; Overend, M; Pedley, I; Riley, M; Watters, J; Whitehead, A | 1 |
| Keefe, DL | 1 |
| Kulp, B; Markman, M; Markman, MR; Peterson, G | 1 |
| Aguerri, MF; Alby, N; Giacchetti, S; Imbeaux, PH | 1 |
| Bremer, K | 1 |
| Marty, M | 1 |
| Blijham, GH | 1 |
| Diehl, V | 1 |
| Hacking, A | 1 |
| Kamanabrou, D | 1 |
| Blijham, GH; Bots, MW; Dijkstra, HJ; Fehmers, MC; Keizer, HJ; Nortier, JW; Siegenbeek van Heukelom, L; Slee, PH; van der Wall, E; Veenhof, CH | 1 |
| Kaizer, L; Laberge, F; Latreille, J; O'Connell, G; Osoba, D; Pater, J; Stewart, D; Venner, P; Warr, D; Wilan, A | 1 |
| Bosanquet, N; Jones, AL; Lee, GJ | 1 |
| Aapro, M; Diehl, V; Kaye, SB; Khayat, D | 1 |
| Davis, A; Erlichman, C; Fine, S; Laberge, F; Lofters, W; Osoba, D; Rusthoven, J; Warr, D; Willan, A; Wilson, K | 1 |
| Amaral, D; Lemerle, J; Murdoch, RD; Southall, DP; Upward, J | 1 |
| Goa, KL; Plosker, GL | 1 |
| Falkson, CI; Falkson, G; Falkson, HC | 1 |
| Addelman, M; Erlichman, C; Fine, S; Murray, C; Warr, D | 1 |
| Nakao, I | 1 |
| Caubel, M; Cupissol, DR; Serrou, B | 1 |
| Brown, GW; Butcher, ME; Kidgell, AE | 1 |
| Cantwell, BM; Carmichael, J; Edwards, CM; Harris, AL; Rapeport, WG; Thompson, S; Zussman, BD | 1 |
| Falkson, G; van Zyl, AJ | 1 |
| Cantwell, BM; Carmichael, J; Edwards, CM; Harris, AL; Rapeport, WG | 1 |
| Brunner, KW; Joss, RA; Pirovino, M; Richner, J; Rohrbach, D; Terrey, JP; Upward, J | 1 |
48 review(s) available for granisetron and Nausea
| Article | Year |
|---|---|
The efficacy and safety of metoclopramide in relieving acute migraine attacks compared with other anti-migraine drugs: a systematic review and network meta-analysis of randomized controlled trials.
Topics: Chlorpromazine; Granisetron; Headache; Humans; Ketorolac; Metoclopramide; Migraine Disorders; Nausea; Network Meta-Analysis; Prochlorperazine; Randomized Controlled Trials as Topic; Sumatriptan; Valproic Acid | 2023 |
Transdermal versus oral granisetron in controlling chemotherapy-induced nausea and vomiting: a meta-analysis.
Topics: Administration, Cutaneous; Administration, Oral; Antiemetics; Antineoplastic Agents; Granisetron; Humans; Nausea; Neoplasms; Randomized Controlled Trials as Topic; Vomiting | 2020 |
Effectiveness of palonosetron versus granisetron in preventing chemotherapy-induced nausea and vomiting: a systematic review and meta-analysis.
Topics: Antiemetics; Antineoplastic Agents; Granisetron; Humans; Nausea; Palonosetron; Quality of Life; Randomized Controlled Trials as Topic; Serotonin 5-HT3 Receptor Antagonists; Vomiting | 2021 |
Granisetron in the treatment of chemotherapy-induced nausea and vomiting (CINV) - is there still a role after comparison with palonosetron?
Topics: Administration, Cutaneous; Antiemetics; Antineoplastic Agents; Clinical Trials as Topic; Dexamethasone; Granisetron; Humans; Isoquinolines; Nausea; Palonosetron; Quinuclidines; Vomiting | 2017 |
Granisetron: a review of pharmacokinetics and clinical experience in chemotherapy induced - nausea and vomiting.
Topics: Antiemetics; Antineoplastic Agents; Dexamethasone; Drug Therapy, Combination; Granisetron; Humans; Nausea; Neoplasms; Quality of Life; Randomized Controlled Trials as Topic; Vomiting | 2017 |
Selective serotonin 3 receptor antagonist treatment for schizophrenia: meta-analysis and systematic review.
Topics: Antipsychotic Agents; Constipation; Double-Blind Method; Drug Therapy, Combination; Granisetron; Haloperidol; Humans; Indoles; Nausea; Ondansetron; Randomized Controlled Trials as Topic; Receptors, Serotonin, 5-HT3; Risperidone; Schizophrenia; Serotonin 5-HT3 Receptor Antagonists; Severity of Illness Index; Symptom Assessment; Treatment Outcome; Tropisetron; Vomiting | 2014 |
WITHDRAWN: Serotonin receptor antagonists for highly emetogenic chemotherapy in adults.
Topics: Adult; Dexamethasone; Granisetron; Humans; Isoquinolines; Nausea; Ondansetron; Palonosetron; Quinuclidines; Randomized Controlled Trials as Topic; Serotonin 5-HT3 Receptor Antagonists; Vomiting | 2013 |
5-Hydroxytryptamine3 receptor antagonists and cardiac side effects.
Topics: Aged; Antiemetics; Antineoplastic Agents; Cardiovascular Diseases; Granisetron; Humans; Isoquinolines; Long QT Syndrome; Nausea; Neoplasms; Ondansetron; Palonosetron; Quinuclidines; Serotonin 5-HT3 Receptor Antagonists; Vomiting | 2014 |
Prevention of cisplatin-based chemotherapy-induced delayed nausea and vomiting using triple antiemetic regimens: a mixed treatment comparison.
Topics: Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Aprepitant; Cisplatin; Dexamethasone; Drug Therapy, Combination; Granisetron; Humans; Isoquinolines; Morpholines; Nausea; Neoplasms; Network Meta-Analysis; Ondansetron; Palonosetron; Quinuclidines; Randomized Controlled Trials as Topic; Spiro Compounds; Treatment Outcome; Vomiting | 2016 |
Management of chemotherapy-induced nausea and vomiting in patients receiving multiple-day highly or moderately emetogenic chemotherapy: role of transdermal granisetron.
Topics: Antiemetics; Antineoplastic Agents; Granisetron; Humans; Nausea; Transdermal Patch; Vomiting | 2016 |
Granisetron Extended-Release Injection: A Review in Chemotherapy-Induced Nausea and Vomiting.
Topics: Animals; Antiemetics; Antineoplastic Agents; Delayed-Action Preparations; Granisetron; Humans; Injections; Nausea; Neoplasms; Vomiting | 2016 |
[Prophylaxis of chemotherapy-induced vomiting and nausea].
Topics: Adrenal Cortex Hormones; Antiemetics; Antineoplastic Agents; Aprepitant; Granisetron; Humans; Morpholines; Nausea; Neurokinin-1 Receptor Antagonists; Ondansetron; Primary Prevention; Serotonin 5-HT3 Receptor Antagonists; Time Factors; Vomiting | 2008 |
[Management of chemotherapy-induced emesis: what is the standard after 20 years of clinical research].
Topics: Antineoplastic Combined Chemotherapy Protocols; Benchmarking; Dexamethasone; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Granisetron; Humans; Indoles; Metoclopramide; Nausea; Ondansetron; Premedication; Randomized Controlled Trials as Topic; Research; Serotonin 5-HT3 Receptor Antagonists; Tropisetron; Vomiting | 1998 |
Transdermal granisetron.
Topics: Administration, Oral; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Drug Administration Schedule; Drug Therapy, Combination; Female; Granisetron; Humans; Infusions, Intravenous; Male; Molecular Structure; Nausea; Receptors, Neurokinin-1; Receptors, Serotonin; Remission Induction; Serotonin; Serotonin Antagonists; Serotonin Receptor Agonists; Severity of Illness Index; Sex Factors; Treatment Outcome; Vomiting | 2009 |
Serotonin receptor antagonists for highly emetogenic chemotherapy in adults.
Topics: Adult; Dexamethasone; Granisetron; Humans; Isoquinolines; Nausea; Ondansetron; Palonosetron; Quinuclidines; Randomized Controlled Trials as Topic; Serotonin 5-HT3 Receptor Antagonists; Vomiting | 2010 |
Gastrointestinal symptoms in cancer patients with advanced disease: new methodologies, insights, and a proposed approach.
Topics: Antiemetics; Antineoplastic Agents; Dexamethasone; Gastrointestinal Diseases; Granisetron; Humans; Isoquinolines; Nausea; Neoplasms; Palliative Care; Palonosetron; Quinuclidines; Serotonin Antagonists; Treatment Outcome; Vomiting; Zingiber officinale | 2012 |
Progress in preventing chemotherapy-induced nausea and vomiting.
Topics: Antiemetics; Antineoplastic Agents; Dexamethasone; Granisetron; Humans; Indoles; Nausea; Neurotransmitter Agents; Ondansetron; Quinolizines; Vomiting | 2002 |
Granisetron: is there a dose-response effect on nausea and vomiting?
Topics: Animals; Antineoplastic Agents; Disease Models, Animal; Dose-Response Relationship, Drug; Granisetron; Humans; Nausea; Receptors, Serotonin; Receptors, Serotonin, 5-HT3; Serotonin Antagonists; Vomiting | 2003 |
Granisetron in the control of nausea and vomiting associated with bone marrow transplantation: a review of its efficacy and tolerability.
Topics: Administration, Oral; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Granisetron; Half-Life; Humans; Infusions, Intravenous; Nausea; Vomiting | 2003 |
Granisetron: new insights into its use for the treatment of chemotherapy-induced nausea and vomiting.
Topics: Antiemetics; Antineoplastic Agents; Clinical Trials as Topic; Granisetron; Humans; Indoles; Nausea; Ondansetron; Quinolizines; Serotonin Antagonists; Vomiting | 2003 |
First choice for radiation-induced nausea and vomiting--the efficacy and safety of granisetron.
Topics: Age Factors; Aged; Antiemetics; Drug Resistance; Granisetron; Humans; Nausea; Neoplasms; Ondansetron; Radiotherapy; Receptors, Dopamine; Serotonin Antagonists; Vomiting | 2004 |
Granisetron: an update on its clinical use in the management of nausea and vomiting.
Topics: Antiemetics; Antineoplastic Agents; Dose-Response Relationship, Drug; Drug Interactions; Granisetron; Heart; Humans; Liver Failure; Nausea; Neoplasms; Radiotherapy; Renal Insufficiency; Vomiting | 2004 |
Granisetron in the control of radiotherapy-induced nausea and vomiting: a comparison with other antiemetic therapies.
Topics: Antiemetics; Antineoplastic Agents; Combined Modality Therapy; Granisetron; Humans; Nausea; Neoplasms; Radiotherapy; Serotonin Antagonists; Vomiting | 2005 |
[Medical treatment of chemotherapy-induced nausea and vomiting].
Topics: Antiemetics; Antineoplastic Agents; Aprepitant; Benzodiazepines; Dexamethasone; Drug Interactions; Drug Therapy, Combination; Evidence-Based Medicine; Ghrelin; Glucocorticoids; Granisetron; Humans; Isoquinolines; Morpholines; Nausea; Neurokinin-1 Receptor Antagonists; Olanzapine; Palonosetron; Peptide Hormones; Practice Guidelines as Topic; Quinuclidines; Serotonin Antagonists; Vomiting | 2007 |
Is ondansetron more effective than granisetron for chemotherapy-induced nausea and vomiting? A review of comparative trials.
Topics: Antiemetics; Antineoplastic Agents; Clinical Trials as Topic; Evidence-Based Medicine; Granisetron; Humans; Meta-Analysis as Topic; Nausea; Ondansetron; Practice Guidelines as Topic; Randomized Controlled Trials as Topic; Research Design; Serotonin Antagonists; Treatment Outcome; Vomiting | 2007 |
Granisetron. An update of its therapeutic use in nausea and vomiting induced by antineoplastic therapy.
Topics: Adult; Antineoplastic Agents; Child; Granisetron; Humans; Nausea; Randomized Controlled Trials as Topic; Vomiting | 1994 |
Granisetron.
Topics: Antineoplastic Agents; Clinical Trials as Topic; Dose-Response Relationship, Drug; Granisetron; Nausea; Vomiting | 1995 |
Inconsistency of prognostic factors for post-chemotherapy nausea and vomiting.
Topics: Antiemetics; Antineoplastic Agents; Cisplatin; Dexamethasone; Doxorubicin; Female; Granisetron; Humans; Male; Methylprednisolone; Metoclopramide; Middle Aged; Nausea; Neoplasms; Prognosis; Randomized Controlled Trials as Topic; Serotonin Antagonists; Treatment Outcome; Vomiting | 1994 |
Granisetron (Kytril) clinical safety and tolerance.
Topics: Antineoplastic Agents; Clinical Trials as Topic; Dose-Response Relationship, Drug; Drug Tolerance; Female; Granisetron; Humans; Infusions, Intravenous; Male; Nausea; Neoplasms; Vomiting | 1994 |
The clinical role of granisetron (Kytril) in the prevention of chemotherapy-induced emesis.
Topics: Antineoplastic Agents; Cisplatin; Clinical Trials as Topic; Granisetron; Humans; Nausea; Neoplasms; Serotonin Antagonists; Vomiting | 1994 |
Efficacy and safety of granisetron (Kytril) in two special patient populations: children and adults with impaired hepatic function.
Topics: Adult; Antineoplastic Agents; Child; Child, Preschool; Chlorpromazine; Clinical Trials as Topic; Dexamethasone; Granisetron; Humans; Infant; Liver Failure; Liver Neoplasms; Nausea; Neoplasms; Vomiting | 1994 |
Further profiles of granisetron (Kytril): effect on quality of life and pharmacoeconomics.
Topics: Antineoplastic Agents; Clinical Trials as Topic; Granisetron; Health Care Costs; Humans; Nausea; Neoplasms; Quality of Life; United States; Vomiting | 1994 |
[An outline of 5-HT3 receptor antagonists (2)--In clinical applications].
Topics: Antineoplastic Agents; Granisetron; Humans; Metoclopramide; Nausea; Ondansetron; Serotonin Antagonists; Vomiting | 1993 |
Review of experience with ondansetron and granisetron.
Topics: Antiemetics; Antineoplastic Agents; Granisetron; Humans; Indazoles; Nausea; Ondansetron; Serotonin Antagonists; Vomiting | 1993 |
Progress in reducing nausea and emesis. Comparisons of ondansetron (Zofran), granisetron (Kytril), and tropisetron (Navoban).
Topics: Antiemetics; Antineoplastic Agents; Granisetron; Humans; Indoles; Nausea; Ondansetron; Serotonin Antagonists; Tropisetron; Vomiting | 1995 |
[Prevention and treatment of postoperative nausea and vomiting with 5-HT3-receptor blockers].
Topics: Antiemetics; Clinical Trials as Topic; Dose-Response Relationship, Drug; Granisetron; Humans; Indoles; Infusions, Intravenous; Nausea; Ondansetron; Postoperative Complications; Quinolizines; Serotonin Antagonists; Tropisetron; Vomiting | 1996 |
[A new antiemetic ramosetron hydrochloride].
Topics: Animals; Antiemetics; Antineoplastic Agents; Benzimidazoles; Granisetron; Guinea Pigs; Humans; Male; Nausea; Ondansetron; Serotonin Antagonists; Vomiting | 1997 |
[Recent improvements in antiemetic therapy].
Topics: Antiemetics; Antineoplastic Agents; Cisplatin; Dexamethasone; Drug Therapy, Combination; Granisetron; Humans; Indoles; Metoclopramide; Nausea; Ondansetron; Phenothiazines; Serotonin Antagonists; Tropisetron; Vomiting | 1997 |
5-HT3-receptor antagonists: a review of pharmacology and clinical efficacy.
Topics: Antiemetics; Antineoplastic Agents; Granisetron; Humans; Nausea; Ondansetron; Serotonin Antagonists; Vomiting | 1997 |
Efficacy of 5-HT3 receptor antagonists in radiotherapy-induced nausea and vomiting: a quantitative systematic review.
Topics: Antiemetics; Granisetron; Humans; Nausea; Ondansetron; Radiotherapy; Randomized Controlled Trials as Topic; Serotonin Antagonists; Treatment Outcome; Vomiting | 1998 |
Granisetron. A pharmacoeconomic evaluation of its use in the prophylaxis of chemotherapy-induced nausea and vomiting.
Topics: Adult; Antiemetics; Antineoplastic Agents; Granisetron; Humans; Nausea; Quality of Life; Serotonin Antagonists; Vomiting | 1996 |
Antiemetic therapy for high-dose chemotherapy with transplantation: report of a retrospective analysis of a 5-HT(3) regimen and literature review.
Topics: Administration, Oral; Adrenal Cortex Hormones; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Antipsychotic Agents; Bone Marrow Transplantation; Drug Combinations; Granisetron; Humans; Infusions, Intravenous; Nausea; Ondansetron; Phenothiazines; Retrospective Studies; Safety; Serotonin Antagonists; Transplantation Conditioning; Treatment Outcome; Vomiting | 1999 |
Granisetron is equivalent to ondansetron for prophylaxis of chemotherapy-induced nausea and vomiting: results of a meta-analysis of randomized controlled trials.
Topics: Antiemetics; Antineoplastic Agents; Cross-Over Studies; Granisetron; Humans; Nausea; Neoplasms; Ondansetron; Randomized Controlled Trials as Topic; Serotonin Antagonists; Therapeutic Equivalency; Vomiting | 2000 |
The cardiotoxic potential of the 5-HT(3) receptor antagonist antiemetics: is there cause for concern?
Topics: Aged; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Drug Interactions; Electrocardiography; Granisetron; Heart Failure; Humans; Indoles; Middle Aged; Nausea; Neoplasms; Ondansetron; Quinolizines; Serotonin Antagonists; Vomiting | 2002 |
Are granisetron and ondansetron equivalent in the clinic?
Topics: Antiemetics; Antineoplastic Agents; Cisplatin; Granisetron; Humans; Imidazoles; Indazoles; Nausea; Ondansetron; Serotonin Antagonists; Vomiting | 1992 |
Granisetron. A review of its pharmacological properties and therapeutic use as an antiemetic.
Topics: Animals; Antiemetics; Antineoplastic Agents; Female; Granisetron; Humans; Indazoles; Male; Nausea; Neoplasms; Serotonin Antagonists; Vomiting | 1991 |
[Gastrointestinal side effects of anticancer agents and their counter measures].
Topics: Antiemetics; Antineoplastic Agents; Cisplatin; Granisetron; Humans; Indazoles; Nausea; Vomiting | 1990 |
Antiemetic control: 5-HT3 antagonists: review of clinical results, with particular emphasis on ondansetron.
Topics: Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Granisetron; Headache; Humans; Imidazoles; Indazoles; Indoles; Nausea; Ondansetron; Radiation Injuries; Radiotherapy; Serotonin Antagonists; Tropisetron; Vomiting | 1990 |
229 trial(s) available for granisetron and Nausea
| Article | Year |
|---|---|
Palonosetron versus Granisetron in Combination with Aprepitant and Dexamethasone for the Prevention of Chemotherapy-Induced Nausea and Vomiting after Moderately Emetogenic Chemotherapy: A Single-Institutional Retrospective Cohort Study.
Topics: Aged; Antiemetics; Antineoplastic Agents; Aprepitant; Drug Therapy, Combination; Female; Granisetron; Humans; Incidence; Male; Middle Aged; Nausea; Neoplasms; Palonosetron; Retrospective Studies; Treatment Outcome; Vomiting | 2021 |
Efficacy of the granisetron transdermal system for the control of nausea and vomiting induced by highly emetogenic chemotherapy: a multicenter, randomized, controlled trial.
Topics: Antiemetics; Antineoplastic Agents; Double-Blind Method; Granisetron; Humans; Nausea; Ondansetron; Quality of Life; Vomiting | 2023 |
Economic Value of Fosaprepitant-Containing Regimen in the Prevention of Chemotherapy-Induced Nausea and Vomiting in China: Cost-Effectiveness and Budget Impact Analysis.
Topics: Antiemetics; Antineoplastic Agents; Cost-Benefit Analysis; Dexamethasone; Granisetron; Humans; Morpholines; Nausea; Vomiting | 2022 |
Translational and Randomized Study of 5-HT3 Receptor Antagonists for Evaluation of Chemotherapy-induced Nausea and Vomiting Related Biomarkers.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Biomarkers; Female; Granisetron; Humans; Male; Middle Aged; Nausea; Palonosetron; Prospective Studies; Quality of Life; Serotonin 5-HT3 Receptor Antagonists; Vomiting | 2019 |
Efficacy and safety of 5 mg olanzapine combined with aprepitant, granisetron and dexamethasone to prevent carboplatin-induced nausea and vomiting in patients with gynecologic cancer: A multi-institution phase II study.
Topics: Adult; Aged; Antiemetics; Aprepitant; Carboplatin; Dexamethasone; Female; Genital Neoplasms, Female; Granisetron; Humans; Middle Aged; Nausea; Olanzapine; Vomiting | 2020 |
A double-blind, randomized, multicenter phase 3 study of palonosetron vs granisetron combined with dexamethasone and fosaprepitant to prevent chemotherapy-induced nausea and vomiting in patients with breast cancer receiving anthracycline and cyclophospham
Topics: Adult; Aged; Aged, 80 and over; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Dexamethasone; Double-Blind Method; Doxorubicin; Drug Therapy, Combination; Epirubicin; Female; Fluorouracil; Granisetron; Humans; Middle Aged; Morpholines; Nausea; Palonosetron; Patient Reported Outcome Measures; Vomiting | 2020 |
A phase III study of transdermal granisetron versus oral ondansetron for women with gynecologic cancers receiving pelvic chemoradiation.
Topics: Administration, Cutaneous; Adult; Antiemetics; Antineoplastic Agents; Cancer Survivors; Endometrial Neoplasms; Female; Granisetron; Humans; Male; Middle Aged; Nausea; Ondansetron; Quality of Life; Remission Induction; Uterine Cervical Neoplasms; Vaginal Neoplasms; Vomiting | 2021 |
Low-Dose Olanzapine Plus Granisetron and Dexamethasone for Carboplatin-Induced Nausea and Vomiting in Patients with Thoracic Malignancies: A Prospective Multicenter Phase II Trial.
Topics: Carboplatin; Dexamethasone; Granisetron; Humans; Japan; Nausea; Olanzapine; Prospective Studies; Thoracic Neoplasms; Vomiting | 2021 |
Evaluation of clinical outcomes and efficacy of palonosetron and granisetron in combination with dexamethasone in Egyptian patients receiving highly emetogenic chemotherapy.
Topics: Antiemetics; Antineoplastic Agents; Aprepitant; Cisplatin; Cyclophosphamide; Dexamethasone; Doxorubicin; Drug Therapy, Combination; Egypt; Female; Granisetron; Humans; Male; Middle Aged; Nausea; Palonosetron; Quality of Life; Vomiting | 2021 |
Efficacy and safety of fosaprepitant in the prevention of nausea and vomiting following highly emetogenic chemotherapy in Chinese people: A randomized, double-blind, phase III study.
Topics: Adult; Aged; Antiemetics; Antineoplastic Agents; Aprepitant; Asian People; China; Cisplatin; Dexamethasone; Double-Blind Method; Drug Therapy, Combination; Female; Granisetron; Humans; Male; Middle Aged; Morpholines; Nausea; Treatment Outcome; Vomiting; Young Adult | 2017 |
[Electrothermal acupuncture in the prevention and treatment of chemotherapy-induced nausea and vomiting:a randomized controlled trial].
Topics: Acupuncture Therapy; Antiemetics; Antineoplastic Agents; Cisplatin; Granisetron; Humans; Nausea; Neoplasms; Vomiting | 2017 |
A phase 2 study of fosaprepitant combined with high-dose dexamethasone for Japanese cancer patients receiving highly emetogenic chemotherapy.
Topics: Adult; Aged; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Dexamethasone; Drug Therapy, Combination; Female; Gastrointestinal Neoplasms; Granisetron; Humans; Male; Middle Aged; Morpholines; Nausea; Prospective Studies; Serotonin Antagonists; Vomiting | 2018 |
Risk factors associated with chemotherapy-induced nausea and vomiting in the triplet antiemetic regimen including palonosetron or granisetron for cisplatin-based chemotherapy: analysis of a randomized, double-blind controlled trial.
Topics: Adult; Aged; Aged, 80 and over; Antiemetics; Antineoplastic Agents; Aprepitant; Cisplatin; Double-Blind Method; Drug Therapy, Combination; Female; Granisetron; Humans; Japan; Logistic Models; Male; Middle Aged; Multivariate Analysis; Nausea; Palonosetron; Risk Factors; Vomiting | 2019 |
Study protocol for an open-label, single-arm, multicentre phase II trial to evaluate the efficacy and safety of combined triplet therapy and olanzapine for prevention of carboplatin-induced nausea and vomiting in gynaecological cancer patients.
Topics: Antiemetics; Antineoplastic Agents; Aprepitant; Carboplatin; Dexamethasone; Drug Therapy, Combination; Female; Genital Neoplasms, Female; Granisetron; Humans; Morpholines; Nausea; Neurokinin-1 Receptor Antagonists; Olanzapine; Serotonin 5-HT3 Receptor Antagonists; Treatment Outcome; Vomiting | 2019 |
Method for individualized evaluation of antiemetic effect induced by 5-HT3 receptor antagonist.
Topics: Aged; Antiemetics; Creatinine; Female; Granisetron; Humans; Hydroxyindoleacetic Acid; Intestine, Small; Male; Middle Aged; Models, Biological; Nausea; Neoplasms; Receptors, Serotonin, 5-HT3; Serotonin; Serotonin Antagonists | 2013 |
Can granisetron injection used as primary prophylaxis improve the control of nausea and vomiting with low- emetogenic chemotherapy?
Topics: Adult; Aged; Antiemetics; Antineoplastic Agents; Dexamethasone; Drug Therapy, Combination; Female; Granisetron; Humans; Logistic Models; Male; Metoclopramide; Middle Aged; Multivariate Analysis; Nausea; Neoplasms; Vomiting | 2013 |
Pooled analysis of phase III clinical studies of palonosetron versus ondansetron, dolasetron, and granisetron in the prevention of chemotherapy-induced nausea and vomiting (CINV).
Topics: Antiemetics; Antineoplastic Agents; Double-Blind Method; Female; Granisetron; Humans; Indoles; Isoquinolines; Male; Middle Aged; Nausea; Neoplasms; Ondansetron; Palonosetron; Quinolizines; Quinuclidines; Serotonin Antagonists; Treatment Outcome; Vomiting | 2014 |
Effectiveness of palonosetron for preventing delayed chemotherapy-induced nausea and vomiting following moderately emetogenic chemotherapy in patients with gastrointestinal cancer.
Topics: Adult; Aged; Aged, 80 and over; Antiemetics; Antineoplastic Agents; Female; Gastrointestinal Neoplasms; Granisetron; Humans; Isoquinolines; Male; Middle Aged; Nausea; Palonosetron; Prospective Studies; Quinuclidines; Surveys and Questionnaires; Vomiting | 2014 |
Granisetron transdermal system improves refractory nausea and vomiting in gastroparesis.
Topics: Administration, Cutaneous; Adult; Antiemetics; Female; Gastroparesis; Granisetron; Humans; Male; Middle Aged; Nausea; Vomiting | 2014 |
Comparison of an extended-release formulation of granisetron (APF530) versus palonosetron for the prevention of chemotherapy-induced nausea and vomiting associated with moderately or highly emetogenic chemotherapy: results of a prospective, randomized, do
Topics: Adult; Aged; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Delayed-Action Preparations; Double-Blind Method; Female; Granisetron; Humans; Isoquinolines; Male; Middle Aged; Nausea; Neoplasms; Palonosetron; Prospective Studies; Quinuclidines; Severity of Illness Index; Treatment Outcome; Vomiting | 2015 |
Aprepitant, granisetron, and dexamethasone for prevention of chemotherapy-induced nausea and vomiting after high-dose melphalan in autologous transplantation for multiple myeloma: results of a randomized, placebo-controlled phase III trial.
Topics: Aprepitant; Dexamethasone; Double-Blind Method; Granisetron; Hematopoietic Stem Cell Transplantation; Humans; Melphalan; Morpholines; Multiple Myeloma; Nausea; Prospective Studies; Quality of Life; Transplantation, Autologous; Vomiting | 2014 |
A randomized study of the efficacy and safety of transdermal granisetron in the control of nausea and vomiting induced by moderately emetogenic chemotherapy in Korean patients.
Topics: Administration, Cutaneous; Adult; Aged; Antiemetics; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Cisplatin; Female; Fluorouracil; Granisetron; Humans; Leucovorin; Male; Middle Aged; Nausea; Neoplasms; Organoplatinum Compounds; Prospective Studies; Remission Induction; Republic of Korea; Safety; Vomiting | 2015 |
Efficacy of triplet regimen antiemetic therapy for chemotherapy-induced nausea and vomiting (CINV) in bone and soft tissue sarcoma patients receiving highly emetogenic chemotherapy, and an efficacy comparison of single-shot palonosetron and consecutive-da
Topics: Adolescent; Adult; Aged; Antiemetics; Antineoplastic Agents; Aprepitant; Bone Neoplasms; Cross-Over Studies; Dexamethasone; Drug Administration Schedule; Drug Therapy, Combination; Female; Granisetron; Humans; Isoquinolines; Male; Middle Aged; Morpholines; Nausea; Neurokinin-1 Receptor Antagonists; Palonosetron; Quinuclidines; Sarcoma; Serotonin 5-HT3 Receptor Antagonists; Treatment Outcome; Vomiting; Young Adult | 2015 |
Efficacy of palonosetron and 1-day dexamethasone in moderately emetogenic chemotherapy compared with fosaprepitant, granisetron, and dexamethasone: a prospective randomized crossover study.
Topics: Aged; Antiemetics; Antineoplastic Agents; Cross-Over Studies; Dexamethasone; Drug Therapy, Combination; Female; Granisetron; Humans; Isoquinolines; Male; Middle Aged; Morpholines; Nausea; Palonosetron; Patient Preference; Prospective Studies; Quinuclidines; Single-Blind Method; Treatment Outcome; Vomiting | 2015 |
Palonosetron versus granisetron in combination with aprepitant for the prevention of chemotherapy-induced nausea and vomiting in patients with gynecologic cancer.
Topics: Adult; Aged; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Aprepitant; Carboplatin; Cross-Over Studies; Diet; Drug Administration Schedule; Female; Genital Neoplasms, Female; Granisetron; Humans; Isoquinolines; Middle Aged; Morpholines; Nausea; Paclitaxel; Palonosetron; Quinuclidines; Serotonin 5-HT3 Receptor Antagonists; Vomiting | 2015 |
Transdermal granisetron versus palonosetron for prevention of chemotherapy-induced nausea and vomiting following moderately emetogenic chemotherapy: a multicenter, randomized, open-label, cross-over, active-controlled, and phase IV study.
Topics: Administration, Cutaneous; Adult; Aged; Antiemetics; Antineoplastic Agents; Cross-Over Studies; Double-Blind Method; Female; Granisetron; Humans; Isoquinolines; Male; Middle Aged; Nausea; Palonosetron; Patient Satisfaction; Quinuclidines; Remission Induction; Serotonin Antagonists; Vomiting | 2016 |
Slow-release granisetron (APF530) versus palonosetron for chemotherapy-induced nausea/vomiting: analysis by American Society of Clinical Oncology emetogenicity criteria.
Topics: Adult; Aged; Antiemetics; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Delayed-Action Preparations; Female; Granisetron; Humans; Isoquinolines; Male; Middle Aged; Nausea; Neoplasms; Palonosetron; Quinuclidines; Serotonin Antagonists; Treatment Outcome; Vomiting | 2015 |
Efficacy and safety of rolapitant for prevention of chemotherapy-induced nausea and vomiting over multiple cycles of moderately or highly emetogenic chemotherapy.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Dexamethasone; Double-Blind Method; Drug Therapy, Combination; Female; Granisetron; Humans; Male; Middle Aged; Nausea; Neoplasms; Neurokinin-1 Receptor Antagonists; Ondansetron; Randomized Controlled Trials as Topic; Retreatment; Serotonin 5-HT3 Receptor Antagonists; Spiro Compounds; Treatment Outcome; Vomiting; Young Adult | 2016 |
APF530 (granisetron injection extended-release) in a three-drug regimen for delayed CINV in highly emetogenic chemotherapy.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Delayed-Action Preparations; Dexamethasone; Double-Blind Method; Drug Therapy, Combination; Female; Granisetron; Humans; Injections, Subcutaneous; Male; Middle Aged; Morpholines; Nausea; Ondansetron; Treatment Outcome; Vomiting; Young Adult | 2016 |
Control of nausea with palonosetron versus granisetron, both combined with dexamethasone, in patients receiving cisplatin- or anthracycline plus cyclophosphamide-based regimens.
Topics: Anthracyclines; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cyclophosphamide; Dexamethasone; Female; Granisetron; Humans; Isoquinolines; Male; Middle Aged; Nausea; Palonosetron; Quinuclidines; Vomiting | 2016 |
Sequential addition of aprepitant in patients receiving carboplatin-based chemotherapy.
Topics: Adult; Aged; Aged, 80 and over; Antiemetics; Antineoplastic Agents; Aprepitant; Bevacizumab; Carboplatin; Carcinoma, Non-Small-Cell Lung; Dexamethasone; Female; Granisetron; Humans; Lung Neoplasms; Male; Middle Aged; Morpholines; Nausea; Ondansetron; Paclitaxel; Pemetrexed; Vomiting | 2016 |
Aprepitant, granisetron, and dexamethasone versus palonosetron and dexamethasone for prophylaxis of cisplatin-induced nausea and vomiting in patients with upper gastrointestinal cancer: a randomized crossover phase II trial (KDOG 1002).
Topics: Adult; Aged; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Aprepitant; Cisplatin; Cross-Over Studies; Dexamethasone; Esophageal Neoplasms; Female; Granisetron; Humans; Isoquinolines; Male; Middle Aged; Morpholines; Nausea; Palonosetron; Quinuclidines; Serotonin Antagonists; Stomach Neoplasms; Vomiting | 2016 |
Randomized, double-blind, phase III trial of palonosetron versus granisetron in the triplet regimen for preventing chemotherapy-induced nausea and vomiting after highly emetogenic chemotherapy: TRIPLE study.
Topics: Adult; Aged; Antineoplastic Agents; Cisplatin; Double-Blind Method; Drug-Related Side Effects and Adverse Reactions; Female; Granisetron; Humans; Isoquinolines; Male; Middle Aged; Nausea; Neoplasms; Palonosetron; Quinuclidines; Serotonin Antagonists; Vomiting | 2016 |
Transdermal granisetron for the prevention of nausea and vomiting following moderately or highly emetogenic chemotherapy in Chinese patients: a randomized, double-blind, phase III study.
Topics: Administration, Cutaneous; Adolescent; Adult; Aged; Antiemetics; Antineoplastic Agents; Double-Blind Method; Female; Granisetron; Humans; Male; Middle Aged; Nausea; Vomiting; Young Adult | 2016 |
Enhanced tolerability of the 5-hydroxytryptophane challenge test combined with granisetron.
Topics: 5-Hydroxytryptophan; Adolescent; Adult; Antidepressive Agents, Second-Generation; Antiemetics; Area Under Curve; Carbidopa; Cross-Over Studies; Domperidone; Dopamine Agents; Dose-Response Relationship, Drug; Double-Blind Method; Drug Interactions; Granisetron; Humans; Hydrocortisone; Male; Nausea; Prolactin; Vomiting; Young Adult | 2010 |
Palonosetron plus dexamethasone versus granisetron plus dexamethasone for prevention of nausea and vomiting during chemotherapy: a double-blind, double-dummy, randomised, comparative phase III trial.
Topics: Adult; Antiemetics; Antineoplastic Agents; Dexamethasone; Double-Blind Method; Female; Granisetron; Humans; Isoquinolines; Male; Middle Aged; Nausea; Neoplasms; Palonosetron; Quinuclidines; Serotonin Antagonists; Vomiting | 2009 |
Effect of casopitant, a novel NK-1 antagonist, on the pharmacokinetics of dolasetron and granisetron.
Topics: Adolescent; Adult; Antiemetics; Drug Therapy, Combination; Drug-Related Side Effects and Adverse Reactions; Female; Granisetron; Humans; Indoles; Male; Middle Aged; Nausea; Piperazines; Piperidines; Quinolizines; Vomiting; Young Adult | 2009 |
Pharmacokinetics of a granisetron transdermal system for the treatment of chemotherapy-induced nausea and vomiting.
Topics: Administration, Cutaneous; Adolescent; Adult; Aging; Antiemetics; Antineoplastic Agents; Area Under Curve; Biological Availability; Chemistry, Pharmaceutical; Creatinine; Cross-Over Studies; Double-Blind Method; Female; Granisetron; Half-Life; Humans; Male; Middle Aged; Nausea; Sex Characteristics; Vomiting; Young Adult | 2009 |
Randomized controlled study comparing two doses of intravenous granisetron (1 and 3 mg) for acute chemotherapy-induced nausea and vomiting in cancer patients: a non-inferiority trial.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Dose-Response Relationship, Drug; Female; Granisetron; Humans; Infusions, Intravenous; Male; Middle Aged; Nausea; Neoplasm Staging; Neoplasms; Prognosis; Single-Blind Method; Survival Rate; Treatment Outcome; Vomiting; Young Adult | 2009 |
Antiemetic effects of granisetron and dexamethasone combination therapy during cisplatin-containing chemotherapy for head and neck cancer: dexamethasone dosage verification trial.
Topics: Aged; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Appetite; Cisplatin; Cross-Over Studies; Dexamethasone; Drug Therapy, Combination; Female; Granisetron; Head and Neck Neoplasms; Humans; Male; Nausea; Neoplasm Staging; Serotonin 5-HT3 Receptor Antagonists; Serotonin Antagonists; Time Factors; Treatment Outcome; Vomiting | 2009 |
Transdermal granisetron.
Topics: Administration, Oral; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Drug Administration Schedule; Drug Therapy, Combination; Female; Granisetron; Humans; Infusions, Intravenous; Male; Molecular Structure; Nausea; Receptors, Neurokinin-1; Receptors, Serotonin; Remission Induction; Serotonin; Serotonin Antagonists; Serotonin Receptor Agonists; Severity of Illness Index; Sex Factors; Treatment Outcome; Vomiting | 2009 |
Randomized, double-blind, crossover study of palonosetron compared with granisetron for the prevention of chemotherapy-induced nausea and vomiting in a Chinese population.
Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Asian People; China; Cross-Over Studies; Double-Blind Method; Female; Granisetron; Humans; Isoquinolines; Male; Middle Aged; Nausea; Neoplasms; Palonosetron; Quinuclidines; Serotonin Antagonists; Survival Rate; Treatment Outcome; Vomiting; Young Adult | 2011 |
Antiemetic activity of megestrol acetate in patients receiving chemotherapy.
Topics: Adult; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Cross-Over Studies; Drug Therapy, Combination; Female; Granisetron; Humans; Male; Megestrol; Metoclopramide; Middle Aged; Nausea; Neoplasms; Single-Blind Method; Treatment Outcome; Vomiting | 2011 |
Multicenter, phase II, placebo-controlled, double-blind, randomized study of aprepitant in Japanese patients receiving high-dose cisplatin.
Topics: Aged; Anorexia; Antineoplastic Combined Chemotherapy Protocols; Aprepitant; Asian People; Cisplatin; Constipation; Dexamethasone; Double-Blind Method; Drug Administration Schedule; Female; Granisetron; Hiccup; Humans; Japan; Male; Middle Aged; Morpholines; Nausea; Neoplasms; Placebos; Treatment Outcome | 2010 |
Efficacy and tolerability of transdermal granisetron for the control of chemotherapy-induced nausea and vomiting associated with moderately and highly emetogenic multi-day chemotherapy: a randomized, double-blind, phase III study.
Topics: Administration, Cutaneous; Administration, Oral; Adult; Aged; Antiemetics; Antineoplastic Agents; Delayed-Action Preparations; Double-Blind Method; Female; Granisetron; Humans; Male; Middle Aged; Nausea; Neoplasms; Vomiting | 2011 |
The NK-1 receptor-antagonist aprepitant in high-dose chemotherapy (high-dose melphalan and high-dose T-ICE: paclitaxel, ifosfamide, carboplatin, etoposide): efficacy and safety of a triple antiemetic combination.
Topics: Adult; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Aprepitant; Carboplatin; Drug Combinations; Drug-Related Side Effects and Adverse Reactions; Etoposide; Female; Granisetron; Humans; Ifosfamide; Male; Melphalan; Middle Aged; Morpholines; Nausea; Neurokinin-1 Receptor Antagonists; Paclitaxel; Treatment Outcome; Vomiting; Young Adult | 2011 |
Pharmacokinetics of aprepitant and dexamethasone after administration of chemotherapeutic agents and effects of plasma substance P concentration on chemotherapy-induced nausea and vomiting in Japanese cancer patients.
Topics: Adult; Aged; Anti-Inflammatory Agents; Antiemetics; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Aprepitant; Area Under Curve; Carcinoma, Non-Small-Cell Lung; Dexamethasone; Drug Therapy, Combination; Female; Granisetron; Humans; Immunoenzyme Techniques; Japan; Lung Neoplasms; Male; Mesothelioma; Middle Aged; Morpholines; Nausea; Small Cell Lung Carcinoma; Substance P; Vomiting; Young Adult | 2011 |
Comparative trial of two intravenous doses of granisetron (1 versus 3 mg) in the prevention of chemotherapy-induced acute emesis: a double-blind, randomized, non-inferiority trial.
Topics: Adult; Aged; Aged, 80 and over; Antiemetics; Antineoplastic Agents; Dexamethasone; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Female; Granisetron; Humans; Infusions, Intravenous; Male; Middle Aged; Nausea; Neoplasms; Treatment Outcome; Vomiting; Young Adult | 2012 |
Ondansetron versus granisetron in the prevention of chemotherapy induced nausea and vomiting in children with acute lymphoblastic leukemia.
Topics: Antiemetics; Antineoplastic Agents; Child; Child, Preschool; Double-Blind Method; Female; Granisetron; Humans; Male; Nausea; Ondansetron; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Serotonin Antagonists; Vomiting | 2011 |
Effect of ginger on acute and delayed chemotherapy-induced nausea and vomiting: a pilot, randomized, open-label clinical trial.
Topics: Adult; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Dexamethasone; Drug Therapy, Combination; Etoposide; Female; Granisetron; Humans; Middle Aged; Nausea; Pilot Projects; Prevalence; Severity of Illness Index; Taxoids; Time Factors; Vomiting; Zingiber officinale | 2012 |
Prevention of delayed nausea: a University of Rochester Cancer Center Community Clinical Oncology Program study of patients receiving chemotherapy.
Topics: Antiemetics; Antineoplastic Agents; Aprepitant; Dexamethasone; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Female; Granisetron; Humans; Intention to Treat Analysis; Isoquinolines; Male; Middle Aged; Morpholines; Nausea; Neurokinin-1 Receptor Antagonists; Palonosetron; Prochlorperazine; Quinuclidines; Serotonin Antagonists | 2012 |
Efficacy and safety of single-dose fosaprepitant in the prevention of chemotherapy-induced nausea and vomiting in patients receiving high-dose cisplatin: a multicentre, randomised, double-blind, placebo-controlled phase 3 trial.
Topics: Adult; Aged; Aprepitant; Cisplatin; Dexamethasone; Double-Blind Method; Drug-Related Side Effects and Adverse Reactions; Female; Granisetron; Humans; Male; Middle Aged; Morpholines; Nausea; Neoplasms; Vomiting | 2013 |
Combination therapy with granisetron, methylprednisolone and droperidol as an antiemetic prophylaxis in CDDP-induced delayed emesis for gynecologic cancer.
Topics: Antiemetics; Antineoplastic Agents; Cisplatin; Cross-Over Studies; Droperidol; Drug Therapy, Combination; Female; Granisetron; Humans; Methylprednisolone; Middle Aged; Nausea; Ovarian Neoplasms; Premedication; Uterine Neoplasms; Vomiting | 2003 |
[Nausea disintegrating buccal tablet in the prevention of gastrointestinal reaction induced by anticancer drugs].
Topics: Adolescent; Adult; Aged; Antiemetics; Antineoplastic Agents; Cisplatin; Digestive System; Doxorubicin; Female; Granisetron; Humans; Male; Middle Aged; Nausea; Ondansetron; Tablets; Treatment Outcome; Vomiting | 2002 |
Comparative study of low-dose oral granisetron plus dexamethasone and high-dose metoclopramide plus dexamethasone in prevention of nausea and vomiting induced by CHOP-therapy in young patients with non-Hodgkin's lymphoma.
Topics: Administration, Oral; Adolescent; Adult; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Chi-Square Distribution; Cross-Over Studies; Cyclophosphamide; Dexamethasone; Dose-Response Relationship, Drug; Double-Blind Method; Doxorubicin; Drug Therapy, Combination; Female; Follow-Up Studies; Granisetron; Humans; Lymphoma, Non-Hodgkin; Male; Metoclopramide; Middle Aged; Nausea; Patient Satisfaction; Prednisone; Probability; Treatment Outcome; Vincristine; Vomiting | 2002 |
Granisetron versus granisetron/dexamethasone combination for the treatment of nausea, retching, and vomiting after major gynecologic surgery: a randomized, double-blind study.
Topics: Adult; Aged; Anesthesia, General; Antiemetics; Dexamethasone; Double-Blind Method; Drug Therapy, Combination; Female; Granisetron; Gynecologic Surgical Procedures; Humans; Middle Aged; Nausea; Time Factors; Treatment Outcome; Vomiting | 2003 |
A comparison of granisetron, droperidol, and metoclopramide in the treatment of established nausea and vomiting after breast surgery: a double-blind, randomized, controlled trial.
Topics: Adult; Aged; Anesthesia, General; Antiemetics; Double-Blind Method; Droperidol; Female; Granisetron; Humans; Mastectomy; Metoclopramide; Middle Aged; Nausea; Prospective Studies; Treatment Outcome; Vomiting | 2003 |
Clinical comparison of the selective serotonin3 antagonists ramosetron and granisetron in treating acute chemotherapy-induced emesis, nausea and anorexia.
Topics: Adolescent; Adult; Aged; Anorexia; Antiemetics; Antineoplastic Agents; Benzimidazoles; Cisplatin; Cross-Over Studies; Doxorubicin; Female; Granisetron; Humans; Lung Neoplasms; Male; Middle Aged; Nausea; Serotonin Antagonists; Single-Blind Method; Vomiting, Anticipatory | 2002 |
The cardiovascular safety of high-dose intravenous granisetron in cancer patients receiving highly emetogenic chemotherapy.
Topics: Adult; Antiemetics; Antineoplastic Agents; Area Under Curve; Cardiovascular Diseases; Electrocardiography; Female; Granisetron; Half-Life; Humans; Male; Middle Aged; Nausea; Neoplasms; Vomiting | 2004 |
[Preventive effects of ramosetron and granisetron in prevention of gastrointestinal reaction associated with chemotherapeutic agents: a comparative study].
Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Appetite; Benzimidazoles; Cisplatin; Doxorubicin; Female; Granisetron; Humans; Male; Middle Aged; Nausea; Vomiting | 2003 |
Antiemetic effectiveness of ondansetron and granisetron in patients with breast cancer treated with cyclophosphamide.
Topics: Adult; Antiemetics; Antineoplastic Agents; Breast Neoplasms; Cancer Care Facilities; Cohort Studies; Cyclophosphamide; Dexamethasone; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Granisetron; Humans; Infusions, Intravenous; Injections, Intravenous; Logistic Models; Middle Aged; Nausea; Ondansetron; Retrospective Studies; Time Factors; Vomiting | 2004 |
Granisetron vs dolasetron for acute chemotherapy-induced nausea and vomiting (CINV) in high and moderately high emetogenic chemotherapy: an open-label pilot study.
Topics: Antiemetics; Drug-Related Side Effects and Adverse Reactions; Female; Granisetron; Humans; Indoles; Male; Middle Aged; Nausea; Neoplasms; Quinolizines; United States; Vomiting | 2004 |
Granisetron vs ondansetron for prevention of nausea and vomiting in hematopoietic stem cell transplant patients: results of a prospective, double-blind, randomized trial.
Topics: Antiemetics; Double-Blind Method; Female; Granisetron; Hematopoietic Stem Cell Transplantation; Humans; Male; Middle Aged; Multicenter Studies as Topic; Nausea; Ondansetron; Prospective Studies; Transplantation Conditioning; Vomiting | 2004 |
Granisetron and ondansetron for prevention of nausea and vomiting in patients undergoing modified radical mastectomy.
Topics: Adult; Aged; Analysis of Variance; Anesthesia, General; Breast Neoplasms; Chi-Square Distribution; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Follow-Up Studies; Granisetron; Humans; Infusions, Intravenous; Mastectomy, Modified Radical; Middle Aged; Nausea; Ondansetron; Preoperative Care; Probability; Reference Values; Risk Assessment; Treatment Outcome; Vomiting | 2004 |
Antiemetic efficacy of an oral suspension of granisetron plus dexamethasone and influence of quality of life on risk for nausea and vomiting.
Topics: Administration, Oral; Adolescent; Adult; Aged; Antiemetics; Antineoplastic Agents; Dexamethasone; Drug Combinations; Female; Granisetron; Humans; Male; Middle Aged; Nausea; Neoplasms; Treatment Outcome; Vomiting | 2005 |
Midazolam for acute emesis refractory to dexamethasone and granisetron after highly emetogenic chemotherapy: a phase II study.
Topics: Adult; Aged; Analysis of Variance; Antineoplastic Agents; Cisplatin; Dexamethasone; Female; Granisetron; Humans; Hypnotics and Sedatives; Male; Midazolam; Middle Aged; Nausea; Neoplasms; Statistics, Nonparametric; Treatment Outcome; Vomiting | 2005 |
The effects of ondansetron and granisetron on electrocardiography in children receiving chemotherapy for acute leukemia.
Topics: Adolescent; Antiemetics; Antimetabolites, Antineoplastic; Child; Child, Preschool; Electrocardiography; Female; Granisetron; Heart Rate; Humans; Male; Methotrexate; Nausea; Ondansetron; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Serotonin Antagonists; Vomiting | 2005 |
Comparative clinical study of the anti-emetic effects of oral ramosetron and injected granisetron in patients with malignant glioma undergoing ACNU chemotherapy.
Topics: Adult; Aged; Anorexia; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Benzimidazoles; Brain Neoplasms; Female; Glioma; Granisetron; Humans; Injections, Intravenous; Male; Middle Aged; Nausea; Vomiting | 2005 |
Clinical usefulness of oral granisetron hydrochloride for alleviation of delayed nausea and vomiting induced by CPT-11.
Topics: Administration, Oral; Adult; Aged; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Colorectal Neoplasms; Female; Granisetron; Humans; Irinotecan; Male; Middle Aged; Nausea; Pilot Projects; Vomiting | 2005 |
Electrocardiographic findings after 5-HT3 receptor antagonists and chemotherapy in children with cancer.
Topics: Adolescent; Adult; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Electrocardiography; Female; Granisetron; Heart Rate; Humans; Male; Nausea; Neoplasms; Ondansetron; Predictive Value of Tests; Serotonin 5-HT3 Receptor Antagonists; Serotonin Antagonists; Treatment Outcome | 2006 |
Comparison of ramosetron and granisetron for the prevention of acute and delayed emesis in Cisplatin-based chemotherapy: a randomized controlled trial.
Topics: Adult; Aged; Aged, 80 and over; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Benzimidazoles; Cisplatin; Dizziness; Double-Blind Method; Drug Administration Schedule; Endpoint Determination; Female; Granisetron; Headache; Humans; Male; Middle Aged; Nausea; Neoplasms; Vomiting, Anticipatory | 2005 |
Association of the ABCB1 3435C>T polymorphism with antiemetic efficacy of 5-hydroxytryptamine type 3 antagonists.
Topics: Adult; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; ATP-Binding Cassette Transporters; Female; Gene Frequency; Genotype; Granisetron; Humans; Indoles; Male; Middle Aged; Nausea; Neoplasms; Ondansetron; Polymorphism, Single Nucleotide; Prospective Studies; Serotonin 5-HT3 Receptor Antagonists; Serotonin Antagonists; Time Factors; Treatment Outcome; Tropisetron; Vomiting | 2005 |
Contribution to the treatment of nausea and emesis induced by chemotherapy in children and adolescents with osteosarcoma.
Topics: Adolescent; Antiemetics; Antineoplastic Agents; Bone Neoplasms; Child; Dimenhydrinate; Female; Granisetron; Humans; Male; Metoclopramide; Nausea; Osteosarcoma; Prospective Studies; Vomiting | 2006 |
Skipping day 2 antiemetic medications may improve chemotherapy induced delayed nausea and vomiting control: results of two pilot phase II trials.
Topics: Adolescent; Adult; Aged; Analysis of Variance; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Brazil; Dexamethasone; Drug Hypersensitivity; Female; Granisetron; Humans; Hypersensitivity, Delayed; Logistic Models; Male; Metoclopramide; Middle Aged; Nausea; Ondansetron; Pilot Projects; Quality of Life; Research Design; Serotonin Antagonists; Treatment Outcome; Vomiting | 2007 |
A double-blind, crossover, randomized dose-comparison trial of granisetron for the prevention of acute and delayed nausea and emesis in children receiving moderately emetogenic carboplatin-based chemotherapy.
Topics: Adolescent; Adult; Antiemetics; Antineoplastic Agents; Carboplatin; Child; Child, Preschool; Cross-Over Studies; Dose-Response Relationship, Drug; Double Bind Interaction; Drug-Related Side Effects and Adverse Reactions; Female; Granisetron; Humans; Infant; Male; Nausea; Treatment Outcome; Vomiting | 2007 |
Population pharmacokinetics of aprepitant and dexamethasone in the prevention of chemotherapy-induced nausea and vomiting.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Antiemetics; Antineoplastic Agents; Aprepitant; Biological Availability; Dexamethasone; Drug Therapy, Combination; Female; Granisetron; Humans; Infusions, Intravenous; Male; Middle Aged; Models, Biological; Morpholines; Nausea; Vomiting | 2008 |
Comparison of granisetron alone and granisetron plus hydroxyzine hydrochloride for prophylactic treatment of emesis induced by cisplatin chemotherapy.
Topics: Acute Disease; Adult; Aged; Antiemetics; Antineoplastic Agents; Cisplatin; Drug Therapy, Combination; Female; Granisetron; Head and Neck Neoplasms; Humans; Hydroxyzine; Male; Middle Aged; Nausea; Vomiting | 1995 |
[A comparative study of the effect of granisetron and a combination of granisetron plus steroids on cancer chemotherapy induced emesis].
Topics: Adult; Aged; Antiemetics; Antineoplastic Agents; Cisplatin; Dexamethasone; Drug Therapy, Combination; Female; Granisetron; Humans; Infusions, Intravenous; Male; Methylprednisolone Hemisuccinate; Middle Aged; Nausea; Neoplasms; Vomiting | 1995 |
Granisetron-dexamethasone combination reduces postoperative nausea and vomiting.
Topics: Adult; Aged; Anesthesia, General; Dexamethasone; Dizziness; Double-Blind Method; Drug Combinations; Female; Genitalia, Female; Granisetron; Headache; Humans; Middle Aged; Nausea; Placebos; Postoperative Complications; Sleep Stages; Vomiting | 1995 |
A double-blind, randomised, crossover comparison of granisetron and ondansetron in 5-day fractionated chemotherapy: assessment of efficacy, safety and patient preference. The Granisetron Study Group.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Cross-Over Studies; Double-Blind Method; Female; Granisetron; Humans; Male; Middle Aged; Nausea; Neoplasms; Ondansetron; Vomiting | 1994 |
Persistence of efficacy of three antiemetic regimens and prognostic factors in patients undergoing moderately emetogenic chemotherapy. Italian Group for Antiemetic Research.
Topics: Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chi-Square Distribution; Dexamethasone; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Female; Granisetron; Humans; Infusions, Intravenous; Italy; Logistic Models; Male; Middle Aged; Nausea; Prognosis; Vomiting | 1995 |
[Comparison of granisetron alone and granisetron plus dexamethasone or hydroxyzine hydrochloride for the prevention of nausea and vomiting during chemotherapy including cisplatin].
Topics: Adult; Aged; Carcinoma, Squamous Cell; Cisplatin; Dexamethasone; Drug Therapy, Combination; Female; Fluorouracil; Granisetron; Head and Neck Neoplasms; Humans; Hydroxyzine; Male; Middle Aged; Nausea; Vomiting | 1995 |
[The preventive effect of granisetron on digestive tract symptoms induced by arterial infusion of anticancer and hypertensive agents in combination with radiotherapy--a study of forty patients with bladder cancer].
Topics: Aged; Angiotensin II; Anorexia; Antineoplastic Combined Chemotherapy Protocols; Blood Pressure; Child; Cisplatin; Doxorubicin; Female; Granisetron; Humans; Infusions, Intra-Arterial; Methylprednisolone; Nausea; Tegafur; Urinary Bladder Neoplasms; Vomiting | 1995 |
The antiemetic efficacy of prophylactic granisetron in gynecologic surgery.
Topics: Adult; Aged; Double-Blind Method; Female; Genitalia, Female; Granisetron; Humans; Middle Aged; Nausea; Postoperative Complications; Prospective Studies; Vomiting | 1995 |
Comparative clinical trial of granisetron and ondansetron in the prophylaxis of cisplatin-induced emesis. The Granisetron Study Group.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Double-Blind Method; Female; Granisetron; Humans; Male; Middle Aged; Nausea; Neoplasms; Ondansetron; Salvage Therapy; Vomiting | 1995 |
A randomized cross-over study of high-dose metoclopramide plus dexamethasone versus granisetron plus dexamethasone in patients receiving chemotherapy with high-dose cisplatin.
Topics: Adult; Aged; Cisplatin; Cross-Over Studies; Dexamethasone; Drug Therapy, Combination; Female; Granisetron; Humans; Lung Neoplasms; Male; Metoclopramide; Middle Aged; Multivariate Analysis; Nausea; Single-Blind Method; Vomiting | 1994 |
Control of nausea and vomiting by granisetron in ovarian cancer patients treated with different cisplatin-based regimens.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cyclophosphamide; Female; Granisetron; Humans; Nausea; Ovarian Neoplasms; Treatment Outcome; Vomiting | 1994 |
[The prevention of cancer chemotherapy-induced emesis with granisetron and clonazepam].
Topics: Administration, Oral; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Clonazepam; Drug Administration Schedule; Drug Therapy, Combination; Female; Granisetron; Humans; Infusions, Intravenous; Nausea; Ovarian Neoplasms; Uterine Cervical Neoplasms; Uterine Neoplasms; Vomiting | 1995 |
Efficacy and safety of granisetron, a selective 5-hydroxytryptamine-3 receptor antagonist, in the prevention of nausea and vomiting induced by high-dose cisplatin.
Topics: Adolescent; Adult; Aged; Cisplatin; Constipation; Diarrhea; Double-Blind Method; Female; Granisetron; Headache; Humans; Infusions, Intravenous; Male; Middle Aged; Nausea; Neoplasms; Serotonin; United States; Vomiting | 1994 |
Optimal anti-emetic dose of granisetron for preventing postoperative nausea and vomiting.
Topics: Adult; Anesthesia Recovery Period; Anesthesia, Epidural; Double-Blind Method; Fallopian Tubes; Female; Granisetron; Humans; Hysterectomy; Middle Aged; Nausea; Ovariectomy; Placebos; Postoperative Complications; Time Factors; Vomiting | 1994 |
Dexamethasone, granisetron, or both for the prevention of nausea and vomiting during chemotherapy for cancer.
Topics: Acute Disease; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Dexamethasone; Double-Blind Method; Female; Granisetron; Humans; Male; Middle Aged; Nausea; Neoplasms; Prospective Studies; Vomiting | 1995 |
[Clinical effects of granisetron and methylpredonisolone against delayed emesis and anorexia induced by anticancer agents].
Topics: Anorexia; Antineoplastic Agents; Drug Therapy, Combination; Female; Granisetron; Humans; Male; Methylprednisolone; Middle Aged; Nausea; Vomiting | 1994 |
Oral granisetron alone and in combination with dexamethasone: a double-blind randomized comparison against high-dose metoclopramide plus dexamethasone in prevention of cisplatin-induced emesis. The Granisetron Study Group.
Topics: Administration, Oral; Adult; Aged; Chi-Square Distribution; Cisplatin; Constipation; Dexamethasone; Double-Blind Method; Drug Therapy, Combination; Europe; Female; Granisetron; Headache; Humans; Male; Metoclopramide; Middle Aged; Nausea; Prognosis; South Africa; Vomiting | 1994 |
Reduction of postoperative nausea and vomiting with granisetron.
Topics: Adult; Anesthesia, General; Female; Granisetron; Humans; Middle Aged; Nausea; Vomiting | 1994 |
Inconsistency of prognostic factors for post-chemotherapy nausea and vomiting.
Topics: Antiemetics; Antineoplastic Agents; Cisplatin; Dexamethasone; Doxorubicin; Female; Granisetron; Humans; Male; Methylprednisolone; Metoclopramide; Middle Aged; Nausea; Neoplasms; Prognosis; Randomized Controlled Trials as Topic; Serotonin Antagonists; Treatment Outcome; Vomiting | 1994 |
A dose-finding study of granisetron, a novel antiemetic, in patients receiving high-dose cisplatin. Granisetron Study Group.
Topics: Awareness; Blood Pressure; Body Temperature; Cisplatin; Double-Blind Method; Female; Granisetron; Headache; Humans; Male; Middle Aged; Nausea; Neoplasms; Patient Satisfaction; Pulse; Time Factors; Vomiting | 1994 |
Control of emesis by intravenous granisetron in breast cancer patients treated with 5-FU, epirubicin and cyclophosphamide.
Topics: Administration, Oral; Adult; Aged; Breast Neoplasms; Constipation; Cyclophosphamide; Epirubicin; Female; Fluorouracil; Flushing; Granisetron; Headache; Humans; Injections, Intravenous; Metoclopramide; Middle Aged; Nausea; Tablets; Vomiting | 1994 |
[Clinical effects and safety of granisetron administration against CDDP chemotherapy in lung cancer. Lung Cancer Study Group].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Female; Granisetron; Humans; Lung Neoplasms; Male; Middle Aged; Nausea; Vomiting | 1994 |
[Clinical evaluation of granisetron injection against nausea and vomiting induced by anticancer drugs including cisplatin].
Topics: Adult; Aged; Antineoplastic Agents; Cisplatin; Female; Granisetron; Humans; Injections, Intravenous; Male; Middle Aged; Nausea; Neoplasms; Vomiting | 1994 |
Ondansetron versus granisetron in the prevention of chemotherapy-induced nausea and vomiting. Results of a prospective randomized trial.
Topics: Acute Disease; Adult; Aged; Antineoplastic Agents; Cisplatin; Drug Administration Schedule; Female; Granisetron; Humans; Male; Middle Aged; Nausea; Ondansetron; Prospective Studies; Vomiting | 1994 |
Dose finding study of granisetron in patients receiving high-dose cisplatin chemotherapy. The Granisetron Study Group.
Topics: Adolescent; Adult; Aged; Cisplatin; Double-Blind Method; Drug Administration Schedule; Female; Granisetron; Humans; Male; Middle Aged; Nausea; Vomiting | 1994 |
[Comparison of granisetron alone and granisetron plus hydroxyzine hydrochloride for the prophylactic treatment of emesis induced by cisplatin-containing chemotherapy].
Topics: Adult; Aged; Cisplatin; Drug Therapy, Combination; Female; Granisetron; Head and Neck Neoplasms; Humans; Hydroxyzine; Male; Middle Aged; Nausea; Vomiting | 1993 |
[Clinical effects of granisetron and methylprednisolone against nausea, vomiting and anorexia induced by cisplatin].
Topics: Adult; Aged; Anorexia; Cisplatin; Domperidone; Drug Therapy, Combination; Female; Granisetron; Humans; Male; Methylprednisolone; Metoclopramide; Middle Aged; Mouth Neoplasms; Nausea; Vomiting | 1993 |
[Antiemetic efficacy of granisetron in the treatment of pediatric cancer--(1). Clinical evaluation of granisetron at a dose of 40 micrograms/kg].
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Female; Granisetron; Humans; Male; Nausea; Neoplasms; Vomiting | 1993 |
[Antiemetic efficacy of granisetron in pediatric cancer treatment--(2). Comparison of granisetron and granisetron plus methylprednisolone as antiemetic prophylaxis].
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Drug Therapy, Combination; Female; Granisetron; Humans; Male; Methylprednisolone; Nausea; Neoplasms; Vomiting | 1993 |
[Comparative trial of granisetron versus granisetron plus methylprednisolone for the prevention of nausea and vomiting induced by cancer chemotherapy].
Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Child; Child, Preschool; Drug Therapy, Combination; Female; Granisetron; Humans; Male; Methylprednisolone; Middle Aged; Nausea; Vomiting | 1994 |
Evaluation of the bioequivalence of tablet and capsule formulations of granisetron in patients undergoing cytotoxic chemotherapy for malignant disease.
Topics: Adolescent; Adult; Antineoplastic Agents; Capsules; Chemistry, Pharmaceutical; Female; Granisetron; Humans; Male; Nausea; Neoplasms; Tablets; Therapeutic Equivalency; Vomiting | 1993 |
A dose-finding study of granisetron, a novel antiemetic, in patients receiving cytostatic chemotherapy. The Granisetron Study Group.
Topics: Antiemetics; Antineoplastic Agents; Double-Blind Method; Female; Granisetron; Humans; Indazoles; Infant, Newborn; Injections, Intravenous; Nausea; Vomiting | 1993 |
The control of acute cisplatin-induced emesis--a comparative study of granisetron and a combination regimen of high-dose metoclopramide and dexamethasone. Granisetron Study Group.
Topics: Blood Pressure; Cisplatin; Dexamethasone; Drug Therapy, Combination; Female; Granisetron; Humans; Indazoles; Male; Metoclopramide; Middle Aged; Nausea; Neoplasms; Pulse | 1993 |
[Clinical evaluation of granisetron for nausea and vomiting induced by anticancer drugs--optimal dose-finding study].
Topics: Administration, Oral; Adult; Aged; Antiemetics; Cisplatin; Female; Granisetron; Humans; Indazoles; Male; Middle Aged; Nausea; Neoplasms; Vomiting | 1993 |
[Clinical evaluation of granisetron for nausea and vomiting induced by anticancer drugs--multi-centered placebo-controlled double-blind comparative study].
Topics: Administration, Oral; Antiemetics; Cisplatin; Double-Blind Method; Female; Granisetron; Humans; Indazoles; Male; Middle Aged; Nausea; Tablets; Vomiting | 1993 |
[Study on the inhibitory effect of oral granisetron against nausea/vomiting induced by cytosine arabinoside containing chemotherapy for tumors in the hematopoietic organs].
Topics: Administration, Oral; Adult; Aged; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Daunorubicin; Etoposide; Female; Granisetron; Humans; Indazoles; Lymphoma; Male; Middle Aged; Mitoxantrone; Nausea; Vomiting | 1993 |
[Granisetron oral phase III clinical trial--study on the inhibitory effect of granisetron for nausea/vomiting induced by chemotherapy for tumors in the hematopoietic organs].
Topics: Administration, Oral; Adolescent; Adult; Aged; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Drug Administration Schedule; Female; Granisetron; Hodgkin Disease; Humans; Indazoles; Leukemia; Lymphoma, Non-Hodgkin; Male; Middle Aged; Nausea; Vomiting | 1993 |
[Clinical evaluation of granisetron hydrochloride against nausea and vomiting induced by anticancer drugs for gynecological malignant tumors].
Topics: Adult; Aged; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Epirubicin; Female; Granisetron; Humans; Middle Aged; Nausea; Ovarian Neoplasms; Uterine Neoplasms; Vomiting | 1996 |
[Comparison of clinical effects between granisetron alone and combination of granisetron and methylprednisolone against the nausea and vomiting induced by CDDP chemotherapy--comparative study by the cross-over trial. University of Tsukuba Antiemetics Stud
Topics: Aged; Antiemetics; Cisplatin; Cross-Over Studies; Drug Therapy, Combination; Female; Granisetron; Humans; Male; Methylprednisolone; Middle Aged; Nausea; Urogenital Neoplasms; Vomiting | 1996 |
Comparison of granisetron, ondansetron, and tropisetron in the prophylaxis of acute nausea and vomiting induced by cisplatin for the treatment of head and neck cancer: a randomized controlled trial.
Topics: Adult; Aged; Antiemetics; Antineoplastic Agents; Cisplatin; Drug Administration Schedule; Female; Granisetron; Head and Neck Neoplasms; Humans; Indoles; Male; Middle Aged; Nausea; Ondansetron; Prospective Studies; Serotonin Antagonists; Tropisetron; Vomiting | 1996 |
Oral granisetron with or without methylprednisolone versus metoclopramide plus methylprednisolone in the management of delayed nausea and vomiting induced by cisplatin-based chemotherapy. A prospective randomized trial.
Topics: Administration, Oral; Adult; Aged; Antiemetics; Cisplatin; Drug Therapy, Combination; Female; Granisetron; Humans; Male; Methylprednisolone; Metoclopramide; Middle Aged; Nausea; Neoplasms; Prospective Studies; Vomiting | 1995 |
Ondansetron versus granisetron in the prevention of chemotherapy-induced nausea and vomiting.
Topics: Adult; Aged; Antiemetics; Antineoplastic Agents; Granisetron; Humans; Lymphoma, AIDS-Related; Lymphoma, Non-Hodgkin; Middle Aged; Nausea; Ondansetron; Prospective Studies; Vomiting | 1995 |
A double-blind comparison of the efficacy of two dose regimens of oral granisetron in preventing acute emesis in patients receiving moderately emetogenic chemotherapy.
Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Antiemetics; Antineoplastic Agents; Double-Blind Method; Female; Granisetron; Humans; Male; Middle Aged; Nausea; Remission Induction; Sex Factors; Vomiting | 1996 |
Single-dose i.v. granisetron in the prevention of postoperative nausea and vomiting.
Topics: Adult; Aged; Aged, 80 and over; Anesthesia, General; Antiemetics; Dose-Response Relationship, Drug; Double-Blind Method; Female; Granisetron; Humans; Injections, Intravenous; Male; Middle Aged; Nausea; Postoperative Complications; Preanesthetic Medication; Risk Factors; Vomiting | 1996 |
[Efficacy of granisetron rescue therapy for nausea and vomiting induced by cancer chemotherapies in urogenital malignant tumor].
Topics: Adult; Aged; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chlorambucil; Cisplatin; Cyclophosphamide; Dactinomycin; Doxorubicin; Drug Administration Schedule; Female; Granisetron; Humans; Male; Methotrexate; Middle Aged; Nausea; Urogenital Neoplasms; Vinblastine; Vomiting | 1996 |
An open randomised cross-over study on granisetron versus ondansetron in the prevention of acute emesis induced by moderate dose cisplatin-containing regimens.
Topics: Acute Disease; Adult; Aged; Antiemetics; Antineoplastic Agents; Cisplatin; Cross-Over Studies; Female; Granisetron; Humans; Male; Middle Aged; Nausea; Neoplasms; Ondansetron; Vomiting | 1996 |
Prevention of postoperative nausea and vomiting with granisetron: a randomized, double-blind comparison with droperidol.
Topics: Adult; Aged; Antiemetics; Double-Blind Method; Droperidol; Female; Granisetron; Humans; Middle Aged; Nausea; Postoperative Complications; Vomiting | 1995 |
Granisetron (IV) compared with ondansetron (IV plus oral) in the prevention of nausea and vomiting induced by moderately-emetogenic chemotherapy. A cross-over study.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cross-Over Studies; Drug Administration Schedule; Female; Granisetron; Humans; Infusions, Intravenous; Male; Middle Aged; Nausea; Ondansetron; Treatment Outcome; Vomiting | 1995 |
[Comparative trial of granisetron alone and granisetron plus methylprednisolone for prevention of nausea and vomiting during cancer chemotherapy].
Topics: Adult; Aged; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cross-Over Studies; Drug Therapy, Combination; Female; Fluorouracil; Granisetron; Humans; Leucovorin; Lung Neoplasms; Male; Methylprednisolone; Middle Aged; Nausea; Vomiting | 1996 |
Antiemetic effects of granisetron on postoperative nausea and vomiting in patients with and without motion sickness.
Topics: Adult; Antiemetics; Double-Blind Method; Female; Granisetron; Humans; Middle Aged; Motion Sickness; Nausea; Postoperative Complications; Serotonin Antagonists; Vomiting | 1996 |
Granisetron plus dexamethasone in moderately emetogenic chemotherapy: evaluation of activity during three consecutive courses of chemotherapy.
Topics: Adult; Aged; Aged, 80 and over; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Dexamethasone; Drug Therapy, Combination; Evaluation Studies as Topic; Female; Granisetron; Humans; Infusions, Intravenous; Male; Middle Aged; Nausea; Treatment Outcome; Vomiting | 1996 |
Prophylactic antiemetic therapy with ondansetron, tropisetron, granisetron and metoclopramide in patients undergoing laparoscopic cholecystectomy: a randomized, double-blind comparison with placebo.
Topics: Adult; Aged; Antiemetics; Cholecystectomy, Laparoscopic; Double-Blind Method; Female; Granisetron; Humans; Indoles; Male; Metoclopramide; Middle Aged; Nausea; Ondansetron; Postoperative Complications; Prospective Studies; Serotonin Antagonists; Tropisetron; Vomiting | 1996 |
A comparison of the antiemetic efficacy and safety of intramuscular and intravenous formulations of granisetron in patients receiving moderately emetogenic chemotherapy.
Topics: Adult; Aged; Antiemetics; Breast Neoplasms; Cross-Over Studies; Female; Granisetron; Humans; Infusions, Intravenous; Injections, Intramuscular; Male; Middle Aged; Nausea; Neoplasms; Treatment Outcome; Vomiting | 1995 |
The dose-response relation and cost-effectiveness of granisetron for the prophylaxis of pediatric postoperative emesis.
Topics: Adolescent; Antiemetics; Child; Child, Preschool; Cost-Benefit Analysis; Dose-Response Relationship, Drug; Female; Granisetron; Humans; Male; Nausea; Parents; Postoperative Complications; Vomiting | 1996 |
Comparison of Granisetron, ondansetron, and tropisetron in the prophylaxis of acute nausea and vomiting induced by cisplatin for the treatment of head and neck cancer. A randomized controlled trial.
Topics: Acute Disease; Antiemetics; Antineoplastic Agents; Cisplatin; Data Interpretation, Statistical; Granisetron; Humans; Indoles; Nausea; Ondansetron; Randomized Controlled Trials as Topic; Tropisetron | 1996 |
Efficacy and safety of different doses of granisetron for the prophylaxis of cisplatin-induced emesis.
Topics: Adult; Aged; Aged, 80 and over; Antiemetics; Antineoplastic Agents; Appetite; Cisplatin; Female; Follow-Up Studies; Granisetron; Headache; Humans; Injections, Intravenous; Male; Middle Aged; Nausea; Neoplasms; Remission Induction; Safety; Time Factors; Vomiting | 1997 |
[Granisetron versus granisetron plus methylprednisolone in the prevention of chemotherapy induced nausea and vomiting--in adjuvant chemotherapy, including CDDP against gastric cancer].
Topics: Antiemetics; Chemotherapy, Adjuvant; Cisplatin; Female; Gastrectomy; Granisetron; Humans; Male; Methylprednisolone; Middle Aged; Nausea; Stomach Neoplasms; Vomiting | 1997 |
[A comparative study of the effects of granisetron alone and a combination of granisetron plus steroids on CDDP-based combination chemotherapy-induced emesis--outcomes of a multicenter randomized comparative study using the central registration method. Na
Topics: Adult; Aged; Anorexia; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Dexamethasone; Drug Therapy, Combination; Female; Genital Neoplasms, Male; Granisetron; Humans; Kidney Neoplasms; Male; Methylprednisolone; Middle Aged; Nausea; Prostatic Neoplasms; Registries; Testicular Neoplasms; Urinary Bladder Neoplasms; Urologic Neoplasms; Vomiting | 1997 |
A double-blind, randomised comparison of the anti-emetic efficacy of two intravenous doses of dolasetron mesilate and granisetron in patients receiving high dose cisplatin chemotherapy.
Topics: Adult; Aged; Antiemetics; Antineoplastic Agents; Cisplatin; Double-Blind Method; Female; Granisetron; Humans; Indoles; Male; Middle Aged; Nausea; Quinolizines; Serotonin Antagonists; Vomiting | 1996 |
Granisetron reduces the incidence and severity of nausea and vomiting after laparoscopic cholecystectomy.
Topics: Adult; Aged; Analysis of Variance; Antiemetics; Chemoprevention; Cholecystectomy, Laparoscopic; Dopamine Antagonists; Droperidol; Elective Surgical Procedures; Female; Follow-Up Studies; Granisetron; Humans; Incidence; Injections, Intravenous; Male; Middle Aged; Nausea; Placebos; Postoperative Complications; Premedication; Safety; Serotonin Antagonists; Vomiting | 1997 |
[A randomized cross-over comparative study of granisetron alone and combination of granisetron, methylprednisolone and droperidol as antiemetic prophilaxis in CDDP-based chemotherapy for gynecologic cancer].
Topics: Adolescent; Adult; Aged; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cross-Over Studies; Droperidol; Drug Administration Schedule; Drug Therapy, Combination; Female; Genital Neoplasms, Female; Granisetron; Humans; Methylprednisolone; Middle Aged; Nausea; Ovarian Neoplasms; Uterine Neoplasms; Vomiting | 1997 |
Granisetron reduces postoperative nausea and vomiting throughout menstrual cycle.
Topics: Adult; Antiemetics; Double-Blind Method; Female; Granisetron; Humans; Menstrual Cycle; Middle Aged; Nausea; Postoperative Complications; Serotonin Antagonists; Vomiting | 1997 |
Anti-emetic drug effects on cognitive and psychomotor performance: granisetron vs. ondansetron.
Topics: Adolescent; Adult; Affect; Antiemetics; Cognition; Cross-Over Studies; Double-Blind Method; Drug Monitoring; Female; Granisetron; Humans; Male; Nausea; Ondansetron; Psychomotor Performance; Radiotherapy; Vomiting | 1997 |
[Clinical evaluation of 2 mg granisetron tablet for nausea and vomiting induced by anticancer drugs including cisplatin].
Topics: Adult; Aged; Antiemetics; Antineoplastic Agents; Cisplatin; Drug Administration Schedule; Female; Granisetron; Humans; Infusions, Intravenous; Lung Neoplasms; Male; Middle Aged; Nausea; Tablets; Vomiting | 1997 |
[Comparison of effects between single vs five-day injection of granisetron for combination chemotherapy with cisplatin and 5-fluorouracil for head and neck cancer].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Administration Schedule; Female; Fluorouracil; Granisetron; Head and Neck Neoplasms; Humans; Injections; Male; Middle Aged; Nausea; Vomiting | 1997 |
[Clinical evaluation of 2-mg granisetron tablet for nausea and vomiting induced by anticancer drugs including cisplatin].
Topics: Adult; Aged; Antiemetics; Antineoplastic Agents; Cisplatin; Drug Administration Schedule; Female; Granisetron; Humans; Middle Aged; Nausea; Ovarian Neoplasms; Tablets; Uterine Neoplasms; Vomiting | 1997 |
Granisetron reduces incidence of nausea and vomiting after breast surgery.
Topics: Aged; Antiemetics; Double-Blind Method; Female; Granisetron; Humans; Middle Aged; Nausea; Postoperative Complications; Serotonin Antagonists; Vomiting | 1997 |
Prevention of PONV with granisetron, droperidol and metoclopramide in female patients with history of motion sickness.
Topics: Adult; Antiemetics; Double-Blind Method; Droperidol; Female; Granisetron; Humans; Metoclopramide; Middle Aged; Motion Sickness; Nausea; Postoperative Complications; Vomiting | 1997 |
Optimal dose of granisetron for prophylaxis against postoperative emesis after gynecological surgery.
Topics: Adult; Aged; Antiemetics; Female; Genitalia, Female; Granisetron; Humans; Hysterectomy; Middle Aged; Nausea; Ovariectomy; Postoperative Complications; Premedication; Vomiting | 1997 |
Patients' self-reported functional status after granisetron or ondansetron therapy to prevent chemotherapy-induced nausea and vomiting at six cancer centers.
Topics: Adult; Aged; Aged, 80 and over; Antiemetics; Antineoplastic Agents; Female; Granisetron; Humans; Male; Middle Aged; Nausea; Ondansetron; Vomiting | 1997 |
Effective dose of granisetron in the reduction of nausea and vomiting after breast surgery.
Topics: Adult; Aged; Anesthesia; Antiemetics; Breast; Double-Blind Method; Female; Granisetron; Humans; Male; Middle Aged; Nausea; Postoperative Complications; Vomiting | 1997 |
Granisetron reduces the incidence of nausea and vomiting after middle ear surgery.
Topics: Adult; Aged; Anesthesia, General; Antiemetics; Double-Blind Method; Ear, Middle; Female; Granisetron; Humans; Male; Middle Aged; Nausea; Postoperative Complications; Preanesthetic Medication; Vomiting | 1997 |
A double-blind crossover study comparing prophylactic intravenous granisetron alone or in combination with dexamethasone as antiemetic treatment in controlling nausea and vomiting associated with chemotherapy.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antiemetics; Antineoplastic Agents; Cross-Over Studies; Dexamethasone; Double-Blind Method; Drug Therapy, Combination; Female; Glucocorticoids; Granisetron; Humans; Male; Middle Aged; Nausea; Patient Satisfaction; Serotonin Antagonists; Treatment Outcome; Vomiting | 1997 |
A comparative study of intravenous granisetron versus intravenous and oral ondansetron in the prevention of nausea and vomiting associated with moderately emetogenic chemotherapy.
Topics: Administration, Oral; Adult; Aged; Antiemetics; Antineoplastic Agents; Drug Administration Schedule; Female; Granisetron; Humans; Infusions, Intravenous; Male; Middle Aged; Nausea; Ondansetron; Prospective Studies; Vomiting | 1997 |
A double-blind, parallel-group, placebo-controlled, dose-ranging, multicenter study of intravenous granisetron in the treatment of postoperative nausea and vomiting in patients undergoing surgery with general anesthesia.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anesthesia, General; Antiemetics; Double-Blind Method; Female; Granisetron; Humans; Injections, Intravenous; Male; Middle Aged; Nausea; Postoperative Complications; Vomiting | 1997 |
Progress in reducing anticipatory nausea and vomiting: a study of community practice.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antiemetics; Antineoplastic Agents; Female; Granisetron; Humans; Male; Middle Aged; Nausea; Ondansetron; Treatment Outcome; Vomiting | 1998 |
Comparison of single-dose oral granisetron versus intravenous ondansetron in the prevention of nausea and vomiting induced by moderately emetogenic chemotherapy: a multicenter, double-blind, randomized parallel study.
Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Antiemetics; Antineoplastic Agents; Carboplatin; Cyclophosphamide; Dexamethasone; Double-Blind Method; Female; Granisetron; Humans; Injections, Intravenous; Male; Methylprednisolone; Middle Aged; Nausea; Ondansetron; Vomiting | 1998 |
[Efficacy of granisetron, a 5-HT3 antagonist, in the prevention of nausea and vomiting induced by conditioning for hematopoietic stem cell transplantation].
Topics: Adolescent; Adult; Antiemetics; Busulfan; Child; Child, Preschool; Cyclophosphamide; Female; Granisetron; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Infant; Male; Melphalan; Middle Aged; Nausea; Serotonin Antagonists; Transplantation Conditioning; Vomiting; Whole-Body Irradiation | 1998 |
Prevention of postoperative nausea and vomiting with a combination of granisetron and droperidol.
Topics: Adult; Anesthesia, General; Antiemetics; Double-Blind Method; Droperidol; Drug Combinations; Female; Granisetron; Humans; Middle Aged; Nausea; Postoperative Period; Prospective Studies; Serotonin Antagonists; Vomiting | 1998 |
Use of dexamethasone and granisetron in the control of delayed emesis for patients who receive highly emetogenic chemotherapy. National Cancer Institute of Canada Clinical Trials Group.
Topics: Antiemetics; Antineoplastic Agents; Cisplatin; Dexamethasone; Double-Blind Method; Drug Administration Schedule; Female; Granisetron; Humans; Linear Models; Logistic Models; Male; Middle Aged; Nausea; Serotonin Antagonists; Statistics, Nonparametric; Vomiting | 1998 |
Prevention of nausea and vomiting in female patients undergoing breast surgery: a comparison with granisetron, droperidol, metoclopramide and placebo.
Topics: Adult; Antiemetics; Breast Neoplasms; Double-Blind Method; Droperidol; Female; Granisetron; Humans; Metoclopramide; Middle Aged; Nausea; Postoperative Complications; Vomiting | 1998 |
Efficacy of intravenous granisetron to control nausea and vomiting during multiple cycles of cisplatin-based chemotherapy.
Topics: Adult; Aged; Aged, 80 and over; Antiemetics; Antineoplastic Agents; Cisplatin; Double-Blind Method; Drug Evaluation; Female; Granisetron; Humans; Injections, Intravenous; Male; Middle Aged; Nausea; Vomiting | 1998 |
Prevention of PONV with granisetron, droperidol or metoclopramide in patients with postoperative emesis.
Topics: Adult; Double-Blind Method; Droperidol; Female; Gastrointestinal Agents; Granisetron; Humans; Metoclopramide; Middle Aged; Nausea; Postoperative Complications; Serotonin Antagonists; Vomiting | 1998 |
[Effect of granisetron in preventing emesis due to anti-cancer drug (CDDP) administration pulmo-mediastinal malignancies--comparison of simultaneous infusion with the conventional method of administration].
Topics: Aged; Antiemetics; Antineoplastic Agents; Cisplatin; Drug Administration Schedule; Female; Granisetron; Humans; Infusions, Intravenous; Lung Neoplasms; Male; Mediastinal Neoplasms; Middle Aged; Nausea; Vomiting | 1998 |
Granisetron prevents nausea and vomiting during spinal anaesthesia for caesarean section.
Topics: Adult; Anesthesia, Obstetrical; Anesthesia, Spinal; Antiemetics; Cesarean Section; Double-Blind Method; Female; Granisetron; Humans; Nausea; Pregnancy; Vomiting | 1998 |
Single-dose oral granisetron has equivalent antiemetic efficacy to intravenous ondansetron for highly emetogenic cisplatin-based chemotherapy.
Topics: Administration, Oral; Adrenal Cortex Hormones; Adult; Aged; Aged, 80 and over; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Dose-Response Relationship, Drug; Double-Blind Method; Female; Granisetron; Humans; Infusions, Intravenous; Male; Middle Aged; Nausea; Ondansetron | 1998 |
[Clinical study on the inhibitory effect of a 5-HT3 antagonist, granisetron, for nausea and vomiting induced by chemotherapy (CHOP, VEPA, high-dose ETP) for non-Hodgkin's lymphoma].
Topics: Adult; Aged; Aged, 80 and over; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Etoposide; Female; Granisetron; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Nausea; Prednisone; Serotonin Antagonists; Vincristine; Vomiting | 1998 |
Anti-emetic efficacy of prophylactic granisetron, droperidol and metoclopramide in the prevention of nausea and vomiting after laparoscopic cholecystectomy: a randomized, double-blind, placebo-controlled trial.
Topics: Adult; Aged; Antiemetics; Cholecystectomy, Laparoscopic; Double-Blind Method; Droperidol; Female; Granisetron; Humans; Metoclopramide; Middle Aged; Nausea; Vomiting | 1998 |
Prevention of postoperative nausea and vomiting in female patients during menstruation: comparison of droperidol, metoclopramide and granisetron.
Topics: Adult; Antiemetics; Double-Blind Method; Droperidol; Female; Granisetron; Gynecologic Surgical Procedures; Humans; Menstruation; Metoclopramide; Middle Aged; Nausea; Postoperative Complications; Vomiting | 1998 |
[Combination effect of granisetron plus corticosteroid for prevention of cisplatin-induced emesis: a cross-over study comparing methylprednisolone and dexamethasone].
Topics: Adult; Aged; Antiemetics; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cross-Over Studies; Dexamethasone; Drug Therapy, Combination; Endometrial Neoplasms; Epirubicin; Etoposide; Female; Granisetron; Humans; Methylprednisolone; Middle Aged; Nausea; Ovarian Neoplasms; Uterine Neoplasms; Vomiting | 1998 |
Comparison of antiemetic efficacy of granisetron and ondansetron in Oriental patients: a randomized crossover study.
Topics: Adult; Aged; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Cross-Over Studies; Double-Blind Method; Granisetron; Hong Kong; Humans; Middle Aged; Nausea; Ondansetron; Vomiting | 1998 |
Continuous-infusion granisetron compared to ondansetron for the prevention of nausea and vomiting after high-dose chemotherapy.
Topics: Adult; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Breast Neoplasms; Double-Blind Method; Female; Granisetron; Humans; Infusions, Intravenous; Middle Aged; Nausea; Ondansetron; Serotonin Antagonists; Treatment Outcome; Vomiting | 1998 |
Effective dose of granisetron for the prevention of post-operative nausea and vomiting in patients undergoing laparoscopic cholecystectomy.
Topics: Adult; Anesthetics, Inhalation; Antiemetics; Cholecystectomy, Laparoscopic; Double-Blind Method; Elective Surgical Procedures; Female; Granisetron; Humans; Incidence; Injections, Intravenous; Isoflurane; Middle Aged; Nausea; Nitrous Oxide; Oxygen; Placebos; Postoperative Complications; Premedication; Probability; Prospective Studies; Serotonin Antagonists; Vomiting | 1998 |
Use of granisetron in patients refractory to previous treatment with antiemetics.
Topics: Adolescent; Adult; Aged; Antiemetics; Antineoplastic Agents; Child; Cisplatin; Constipation; Drug Resistance; Female; Granisetron; Headache; Humans; Male; Middle Aged; Nausea; Serotonin Antagonists; Treatment Outcome; Vomiting | 1998 |
Prophylactic antiemetic therapy with granisetron-droperidol combination in patients undergoing laparoscopic cholecystectomy.
Topics: Adult; Aged; Anesthetics, Inhalation; Antiemetics; Cholecystectomy, Laparoscopic; Double-Blind Method; Droperidol; Drug Combinations; Female; Follow-Up Studies; Granisetron; Humans; Incidence; Injections, Intravenous; Isoflurane; Middle Aged; Nausea; Nitrous Oxide; Oxygen; Postoperative Complications; Premedication; Remission Induction; Treatment Outcome; Vomiting | 1998 |
Control of delayed nausea and vomiting with granisetron plus dexamethasone or dexamethasone alone in patients receiving highly emetogenic chemotherapy: a double-blind, placebo-controlled, comparative study.
Topics: Adult; Aged; Aged, 80 and over; Antiemetics; Antineoplastic Agents; Cisplatin; Dexamethasone; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Female; Granisetron; Humans; Male; Middle Aged; Nausea; Odds Ratio; Proportional Hazards Models; Serotonin Antagonists; Time Factors; Treatment Outcome; Vomiting | 1998 |
Preoperative oral granisetron prevents postoperative nausea and vomiting.
Topics: Administration, Oral; Adult; Anesthesia; Antiemetics; Double-Blind Method; Female; Granisetron; Gynecologic Surgical Procedures; Humans; Middle Aged; Nausea; Postoperative Complications; Premedication; Prospective Studies; Vomiting | 1998 |
Granisetron and ondansetron for chemotherapy-related nausea and vomiting.
Topics: Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Female; Granisetron; Humans; Male; Middle Aged; Nausea; Neoplasms; Ondansetron; Treatment Outcome; Vomiting | 1998 |
[Granisetron (per os) compared with ondansetron (per os) in the prevention of nausea and vomiting induced by mildly emetogenic chemotherapies. Groupe de Recherches en Cancerologie du Nord].
Topics: Adult; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cross-Over Studies; Cyclophosphamide; Doxorubicin; Female; Granisetron; Humans; Male; Methotrexate; Nausea; Ondansetron; Prednisone; Vindesine; Vomiting | 1998 |
[Efficacy and safety of two methods of administration of granisetron injection for nausea and vomiting induced by chemotherapy for tumors in hematopoietic organs--a randomized crossover comparison between intravenous drip infusion and intravenous bolus in
Topics: Adult; Aged; Aged, 80 and over; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Cross-Over Studies; Drug Administration Schedule; Female; Granisetron; Hematologic Neoplasms; Humans; Infusions, Intravenous; Injections, Intravenous; Male; Middle Aged; Nausea; Vomiting | 1998 |
Granisetron in the prevention of nausea and vomiting after middle-ear surgery: a dose-ranging study.
Topics: Adult; Aged; Antiemetics; Dose-Response Relationship, Drug; Double-Blind Method; Female; Granisetron; Humans; Mastoid; Middle Aged; Nausea; Postoperative Complications; Serotonin Antagonists; Tympanoplasty; Vomiting | 1998 |
[Efficacy of granisetron as anti-emetic agent for emesis induced by intra-arterial injection therapy for hepatocellular carcinoma].
Topics: Adult; Aged; Antiemetics; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Cisplatin; Doxorubicin; Female; Granisetron; Humans; Liver Neoplasms; Male; Middle Aged; Nausea; Vomiting | 1998 |
[Comparison of antiemetic efficacy of granisetron as premedication versus combination therapy of granisetron].
Topics: Aged; Antiemetics; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cross-Over Studies; Double-Blind Method; Female; Granisetron; Humans; Infusions, Intravenous; Male; Middle Aged; Nausea; Neoplasms; Premedication; Vomiting | 1998 |
Prophylactic antiemetic therapy with granisetron-dexamethasone combination in women undergoing breast surgery.
Topics: Adult; Aged; Antiemetics; Dexamethasone; Double-Blind Method; Drug Therapy, Combination; Female; Granisetron; Humans; Mastectomy; Middle Aged; Nausea; Postoperative Complications; Vomiting | 1998 |
A randomized trial of once vs twice daily administration of intravenous granisetron with dexamethosone in patients receiving high-dose cyclophosphamide, thiotepa and carboplatin.
Topics: Adult; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carboplatin; Cyclophosphamide; Dexamethasone; Double-Blind Method; Drug Therapy, Combination; Female; Granisetron; Humans; Injections, Intravenous; Middle Aged; Nausea; Thiotepa | 1998 |
Antiemetic efficacy of granisetron plus dexamethasone in bone marrow transplant patients receiving chemotherapy and total body irradiation.
Topics: Activities of Daily Living; Adult; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Combined Modality Therapy; Cyclophosphamide; Dexamethasone; Diarrhea; Drug Therapy, Combination; Female; Granisetron; Headache; Humans; Male; Middle Aged; Nausea; Premedication; Prospective Studies; Receptors, Serotonin; Receptors, Serotonin, 5-HT3; Safety; Transplantation Conditioning; Treatment Outcome; Vomiting; Whole-Body Irradiation | 1999 |
Oral granisetron as prophylaxis for nausea and vomiting during fluorescein angiography. A multicentre, double-blind, randomised, parallel group, placebo-controlled study.
Topics: Administration, Oral; Adult; Aged; Antiemetics; Double-Blind Method; Female; Fluorescein Angiography; Granisetron; Humans; Male; Middle Aged; Nausea; Vomiting | 1998 |
Antiemetic efficacy of granisetron: a randomized crossover study in patients receiving cisplatin-containing intraarterial chemotherapy.
Topics: Adolescent; Aged; Aged, 80 and over; Antiemetics; Antineoplastic Agents; Cisplatin; Cross-Over Studies; Drug Administration Schedule; Female; Granisetron; Humans; Infusions, Intra-Arterial; Male; Methotrexate; Middle Aged; Nausea; Prospective Studies; Urinary Bladder Neoplasms; Vomiting, Anticipatory | 1999 |
A comparative study of administration methods of granisetron injection used to treat nausea/vomiting induced by cancer chemotherapy without cisplatin in tumors of hematopoietic organs. Keihanshin Study Group of Hematological Malignancies.
Topics: Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Female; Granisetron; Hematologic Neoplasms; Humans; Infusions, Intravenous; Injections, Intravenous; Male; Middle Aged; Nausea; Treatment Outcome; Vomiting | 1999 |
Granisetron, droperidol, and metoclopramide for preventing postoperative nausea and vomiting after thyroidectomy.
Topics: Adult; Antiemetics; Double-Blind Method; Droperidol; Female; Granisetron; Humans; Metoclopramide; Middle Aged; Nausea; Postoperative Complications; Prospective Studies; Thyroidectomy; Treatment Outcome; Vomiting | 1999 |
[Comparative trial of oral granisetron and intravenous ondansetron in patients receiving chemotherapy for breast cancer. Study Group of Granisetron].
Topics: Administration, Oral; Adult; Aged; Antiemetics; Breast Neoplasms; Drug Therapy, Combination; Female; Granisetron; Humans; Injections, Intravenous; Male; Metoclopramide; Middle Aged; Nausea; Ondansetron; Vomiting | 1999 |
Granisetron (Kytril) suppresses methotrexate-induced nausea and vomiting among patients with inflammatory arthritis and is superior to prochlorperazine (Stemetil).
Topics: Antiemetics; Arthritis; Granisetron; Humans; Methotrexate; Nausea; Prochlorperazine; Single-Blind Method; Vomiting | 1999 |
Granisetron compared with prednisolone plus metopimazine as anti-emetic prophylaxis during multiple cycles of moderately emetogenic chemotherapy.
Topics: Adult; Aged; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Dopamine Antagonists; Double-Blind Method; Drug Administration Schedule; Epirubicin; Female; Fluorouracil; Glucocorticoids; Granisetron; Humans; Isonipecotic Acids; Methotrexate; Middle Aged; Nausea; Prednisolone; Serotonin Antagonists; Vomiting | 1999 |
[Efficacy of combination with granisetron and methylprednisolone for nausea, vomiting and appetite loss in remission induction chemotherapy of acute myeloid leukemia--a randomized comparative trial between granisetron alone and granisetron plus methylpred
Topics: Acute Disease; Adult; Aged; Aged, 80 and over; Anorexia; Antiemetics; Antineoplastic Agents; Drug Administration Schedule; Drug Therapy, Combination; Female; Granisetron; Humans; Leukemia, Myeloid; Male; Methylprednisolone; Middle Aged; Nausea; Vomiting, Anticipatory | 1999 |
[Clinical evaluation of granisetron (BRL43694) in nausea and vomiting induced by anticancer drugs--pediatrics].
Topics: Adolescent; Antiemetics; Antineoplastic Agents; Child; Child, Preschool; Cisplatin; Drug Evaluation; Female; Granisetron; Humans; Infant; Leukemia; Male; Nausea; Neoplasms; Vomiting, Anticipatory | 1999 |
A prospective randomized trial of the anti-emetic efficacy of ondansetron and granisetron during bone marrow transplantation.
Topics: Adolescent; Adult; Aged; Antiemetics; Bone Marrow Transplantation; Child; Child, Preschool; Dexamethasone; Double-Blind Method; Female; Granisetron; Humans; Male; Middle Aged; Nausea; Ondansetron; Prospective Studies; Vomiting | 1999 |
[Optimal timing of granisetron administration for the prevention of carboplatin-induced acute emesis].
Topics: Acute Disease; Adult; Aged; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cyclophosphamide; Drug Administration Schedule; Female; Granisetron; Humans; Infusions, Intravenous; Middle Aged; Nausea; Ovarian Neoplasms; Pilot Projects; Prospective Studies; Time Factors; Uterine Neoplasms; Vomiting, Anticipatory | 1999 |
Granisetron, droperidol, and metoclopramide for the treatment of established postoperative nausea and vomiting in women undergoing gynecologic surgery.
Topics: Adult; Anesthesia, General; Antiemetics; Double-Blind Method; Droperidol; Female; Granisetron; Gynecologic Surgical Procedures; Humans; Metoclopramide; Middle Aged; Nausea; Postoperative Complications; Vomiting | 2000 |
Control of high-dose-cisplatin-induced emesis with an all-oral three-drug antiemetic regimen.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Antiemetics; Antineoplastic Agents; Cisplatin; Dexamethasone; Drug Therapy, Combination; Female; Granisetron; Humans; Male; Middle Aged; Nausea; Neoplasms; Pilot Projects; Prochlorperazine; Treatment Outcome; Vomiting | 2000 |
Comparison of granisetron, ondansetron and tropisetron for control of vomiting and nausea induced by cisplatin.
Topics: Adult; Antiemetics; Antineoplastic Agents; Cisplatin; Cost-Benefit Analysis; Female; Granisetron; Humans; Indoles; Injections, Intravenous; Male; Middle Aged; Nausea; Neoplasms; Ondansetron; Treatment Outcome; Tropisetron; Vomiting, Anticipatory | 2000 |
[Oral granisetron solution as prophylaxis for chemotherapy-induced emesis in children: double-blind study of 2 doses].
Topics: Administration, Oral; Adolescent; Antiemetics; Antineoplastic Agents; Child; Child, Preschool; Double-Blind Method; Female; Granisetron; Humans; Infant; Male; Nausea; Vomiting | 2000 |
Antiemetic efficacy of combination therapy with granisetron plus prednisolone plus the dopamine D2 antagonist metopimazine during multiple cycles of moderately emetogenic chemotherapy in patients refractory to previous antiemetic therapy.
Topics: Adult; Aged; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Drug Therapy, Combination; Female; Glucocorticoids; Granisetron; Humans; Isonipecotic Acids; Middle Aged; Nausea; Prednisolone; Treatment Outcome; Vomiting | 2000 |
[Effects of oral 5-HT3 antagonists on chemotherapy-induced emesis in patients with gynecologic cancers].
Topics: Administration, Oral; Antiemetics; Benzimidazoles; Carboplatin; Cisplatin; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Female; Genital Neoplasms, Female; Granisetron; Humans; Indoles; Middle Aged; Nausea; Ondansetron; Paclitaxel; Serotonin Antagonists; Tropisetron; Vomiting | 2000 |
Oral granisetron for the prevention of acute late onset nausea and vomiting in patients treated with moderately emetogenic chemotherapy.
Topics: Administration, Oral; Adolescent; Adult; Aged; Antiemetics; Antineoplastic Agents; Carboplatin; Cyclophosphamide; Double-Blind Method; Doxorubicin; Female; Granisetron; Humans; Male; Middle Aged; Nausea; Neoplasms; Prochlorperazine; Sex Factors; Vomiting, Anticipatory | 2000 |
The effect of tamoxifen and cisplatin on the disease-free and overall survival of patients with high risk malignant melanoma.
Topics: Adult; Aged; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cisplatin; Combined Modality Therapy; Dexamethasone; Disease-Free Survival; Female; Follow-Up Studies; Granisetron; Humans; Life Tables; Lymphatic Metastasis; Male; Melanoma; Middle Aged; Nausea; Neoplasm Metastasis; Neoplasm Staging; Ondansetron; Prognosis; Risk; Skin Neoplasms; Survival Analysis; Tamoxifen; Treatment Outcome; Vomiting | 2000 |
Double-blind, randomized, parallel-group study on the efficacy and safety of oral granisetron and oral ondansetron in the prophylaxis of nausea and vomiting in patients receiving hyperfractionated total body irradiation.
Topics: Adult; Aged; Antiemetics; Bone Marrow Transplantation; Double-Blind Method; Drug Evaluation; Female; Granisetron; Humans; Male; Middle Aged; Nausea; Ondansetron; Serotonin Antagonists; Whole-Body Irradiation | 2000 |
Randomised double blind crossover study comparing ondansetron, granisetron and tropisetron. A cost-benefit analysis.
Topics: Adult; Aged; Antiemetics; Antineoplastic Agents; Cost-Benefit Analysis; Cross-Over Studies; Drug Costs; Female; Granisetron; Health Care Costs; Humans; Indoles; Male; Middle Aged; Nausea; Neoplasms; Ondansetron; Treatment Outcome; Tropisetron; Vomiting | 2000 |
[Clinical evaluation of granisetron hydrochloride for nausea and vomiting induced by oral anticancer drugs].
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Antiemetics; Antineoplastic Agents; Colorectal Neoplasms; Drug Administration Schedule; Female; Granisetron; Humans; Male; Middle Aged; Nausea; Stomach Neoplasms; Tablets; Vomiting, Anticipatory | 2000 |
Comparison of the efficacy and safety of oral granisetron plus dexamethasone with intravenous ondansetron plus dexamethasone to control nausea and vomiting induced by moderate/severe emetogenic chemotherapy.
Topics: Adolescent; Adult; Aged; Antiemetics; Antineoplastic Agents; Dexamethasone; Drug Therapy, Combination; Female; Granisetron; Humans; Male; Middle Aged; Nausea; Ondansetron; Serotonin Antagonists; Vomiting | 2000 |
Randomized, multicenter comparison of oral granisetron and oral ondansetron for emetogenic chemotherapy.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Dexamethasone; Drug Therapy, Combination; Emetics; Female; Granisetron; Humans; Male; Middle Aged; Nausea; Ondansetron | 2000 |
Antiemetic efficacy of three serotonin antagonists during high-dose chemotherapy and autologous stem cell transplantation in malignant lymphoma.
Topics: Adult; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Combined Modality Therapy; Cytarabine; Etoposide; Female; Granisetron; Hematopoietic Stem Cell Transplantation; Humans; Indoles; Lymphoma; Male; Melphalan; Nausea; Ondansetron; Serotonin Antagonists; Transplantation, Autologous; Tropisetron; Vomiting | 2000 |
Randomized trial of ondansetron, granisetron, and tropisetron in the prevention of acute nausea and vomiting.
Topics: Adult; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Female; Granisetron; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppression Therapy; Indoles; Leukemia; Male; Multiple Myeloma; Myelodysplastic Syndromes; Nausea; Ondansetron; Transplantation, Autologous; Transplantation, Homologous; Tropisetron; Vomiting | 2000 |
Effects of nutrients and serotonin 5-HT3 antagonism on symptoms evoked by distal gastric distension in humans.
Topics: Adult; Carbohydrates; Catheterization; Double-Blind Method; Duodenum; Female; Granisetron; Humans; Intubation, Gastrointestinal; Lipids; Male; Middle Aged; Nausea; Nutritional Physiological Phenomena; Pain; Pressure; Proteins; Receptors, Serotonin; Receptors, Serotonin, 5-HT3; Serotonin Antagonists; Stomach | 2001 |
[Evaluation of efficacy of ramosetron orally disintegrating tablets and patient preference as to the dosage form in gynecological cancer chemotherapy].
Topics: Administration, Oral; Adult; Aged; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Benzimidazoles; Endometrial Neoplasms; Female; Granisetron; Humans; Middle Aged; Nausea; Ovarian Neoplasms; Serotonin Antagonists; Uterine Cervical Neoplasms; Uterine Neoplasms; Vomiting, Anticipatory | 2001 |
Comparison of tropisetron and granisetron in the control of nausea and vomiting in children receiving combined cancer chemotherapy.
Topics: Adolescent; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Female; Granisetron; Humans; Indoles; Infant; Male; Nausea; Prospective Studies; Therapeutic Equivalency; Treatment Outcome; Tropisetron; Vomiting | 2001 |
Double-blind comparative trial of oral ondansetron versus oral granisetron versus IV ondansetron in the prevention of nausea and vomiting associated with highly emetogenic preparative regimens prior to stem cell transplantation.
Topics: Administration, Oral; Antiemetics; Costs and Cost Analysis; Double-Blind Method; Female; Granisetron; Hematopoietic Stem Cell Transplantation; Humans; Injections, Intravenous; Male; Middle Aged; Nausea; Ondansetron; Serotonin Antagonists; Therapeutic Equivalency; Transplantation Conditioning; Vomiting | 2001 |
The efficacy and safety of once-daily Kytril (granisetron hydrochloride) tablets in the prophylaxis of nausea and emesis following fractionated upper abdominal radiotherapy.
Topics: Abdomen; Adult; Aged; Aged, 80 and over; Antiemetics; Dose Fractionation, Radiation; Double-Blind Method; Drug Administration Schedule; Female; Granisetron; Humans; Male; Middle Aged; Nausea; Neoplasms; Radiotherapy; Tablets; Vomiting | 2001 |
[Nasea injection in the prophylaxis of gastrointestinal reaction induced by chemotherapeutic agents].
Topics: Adolescent; Adult; Aged; Anorexia; Antiemetics; Benzimidazoles; Cisplatin; Digestive System; Female; Granisetron; Humans; Male; Middle Aged; Mitomycin; Nausea; Vomiting | 2000 |
[The clinical effect of Tropisetron in the prevention of nausea and vomiting induced by anti-cancer drugs].
Topics: Adolescent; Adult; Aged; Antiemetics; Antineoplastic Agents; Cross-Over Studies; Drug Administration Schedule; Female; Granisetron; Humans; Indoles; Male; Middle Aged; Nausea; Tropisetron; Vomiting | 2001 |
The development of a protocol for the use of 5-HT3 antagonists in chemotherapy-induced nausea and vomiting.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Clinical Protocols; Female; Granisetron; Humans; Indoles; Male; Middle Aged; Nausea; Neoplasms; Ondansetron; Receptors, Serotonin; Receptors, Serotonin, 5-HT3; Serotonin Antagonists; Treatment Outcome; Tropisetron; Vomiting | 2001 |
A single-blind study of the efficacy and safety of intravenous granisetron compared with alizapride plus dexamethasone in the prophylaxis and control of emesis in patients receiving 5-day cytostatic therapy. The Granisetron Study Group.
Topics: Adult; Antiemetics; Antineoplastic Agents; Dexamethasone; Drug Therapy, Combination; Female; Granisetron; Humans; Indazoles; Infusions, Intravenous; Male; Middle Aged; Nausea; Pyrrolidines; Single-Blind Method; Vomiting | 1992 |
A comparison of granisetron as a single agent with conventional combination antiemetic therapies in the treatment of cytostatic-induced emesis. The Granisetron Study Group.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antiemetics; Antineoplastic Agents; Cisplatin; Drug Therapy, Combination; Female; Granisetron; Humans; Indazoles; Male; Middle Aged; Nausea; Single-Blind Method; Vomiting | 1992 |
Fractionated chemotherapy--granisetron or conventional antiemetics? The Granisetron Study Group.
Topics: Adult; Antiemetics; Antineoplastic Agents; Dexamethasone; Drug Administration Schedule; Drug Therapy, Combination; Female; Granisetron; Humans; Indazoles; Male; Metoclopramide; Middle Aged; Nausea; Pyrrolidines; Single-Blind Method; Vomiting | 1992 |
Oral granisetron--simple and effective: a preliminary report. The Granisetron Study Group.
Topics: Administration, Oral; Adult; Antiemetics; Antineoplastic Agents; Double-Blind Method; Female; Granisetron; Humans; Indazoles; Male; Middle Aged; Nausea; Vomiting | 1992 |
Intravenous granisetron--establishing the optimal dose. The Granisetron Study Group.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antiemetics; Antineoplastic Agents; Double-Blind Method; Drug Administration Schedule; Female; Granisetron; Humans; Indazoles; Infusions, Intravenous; Male; Middle Aged; Nausea; Vomiting | 1992 |
A randomized trial of two doses of granisetron in the treatment of chemotherapy-induced emesis. Dutch results within a multinational study.
Topics: Adult; Aged; Aged, 80 and over; Antiemetics; Antineoplastic Agents; Cisplatin; Dose-Response Relationship, Drug; Double-Blind Method; Female; Granisetron; Humans; Indazoles; Male; Middle Aged; Nausea; Netherlands; Serotonin Antagonists; Vomiting | 1992 |
A randomised, double-blind comparison of granisetron with high-dose metoclopramide, dexamethasone and diphenhydramine for cisplatin-induced emesis. An NCI Canada Clinical Trials Group Phase III Trial.
Topics: Antiemetics; Cisplatin; Dexamethasone; Diphenhydramine; Double-Blind Method; Drug Therapy, Combination; Female; Granisetron; Humans; Indazoles; Male; Metoclopramide; Middle Aged; Nausea; Vomiting | 1992 |
Superiority of granisetron to dexamethasone plus prochlorperazine in the prevention of chemotherapy-induced emesis.
Topics: Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Dexamethasone; Double-Blind Method; Drug Therapy, Combination; Female; Granisetron; Humans; Indazoles; Male; Middle Aged; Nausea; Prochlorperazine; Serotonin Antagonists; Vomiting | 1991 |
Granisetron. A review of its pharmacological properties and therapeutic use as an antiemetic.
Topics: Animals; Antiemetics; Antineoplastic Agents; Female; Granisetron; Humans; Indazoles; Male; Nausea; Neoplasms; Serotonin Antagonists; Vomiting | 1991 |
High versus low dose granisetron, a selective 5HT3 antagonist, for the prevention of chemotherapy-induced nausea and vomiting.
Topics: Antineoplastic Agents; Double-Blind Method; Drugs, Investigational; Female; Granisetron; Humans; Indazoles; Male; Middle Aged; Nausea; Random Allocation; Serotonin Antagonists; Vomiting | 1990 |
A comparison of two dose levels of granisetron in patients receiving high-dose cisplatin. The Granisetron Study Group.
Topics: Cisplatin; Double-Blind Method; Female; Granisetron; Humans; Indazoles; Male; Middle Aged; Nausea; Neoplasms; Serotonin Antagonists; Time Factors; Vomiting | 1990 |
A comparison of two dose levels of granisetron in patients receiving moderately emetogenic cytostatic chemotherapy. The Granisetron Study Group.
Topics: Antineoplastic Agents; Double-Blind Method; Female; Granisetron; Headache; Humans; Indazoles; Male; Middle Aged; Nausea; Serotonin Antagonists; Time Factors; Vomiting | 1990 |
The efficacy of granisetron as a prophylactic anti-emetic and intervention agent in high-dose cisplatin-induced emesis.
Topics: Adult; Aged; Cisplatin; Double-Blind Method; Female; Granisetron; Humans; Indazoles; Male; Middle Aged; Nausea; Neoplasms; Serotonin Antagonists; Sex Factors; Time Factors; Vomiting | 1990 |
108 other study(ies) available for granisetron and Nausea
| Article | Year |
|---|---|
Comparison of the Antiemetic Effect of Aprepitant/granisetron and Palonosetron Combined with Dexamethasone in Gynecological Cancer Patients Treated with Paclitaxel and Carboplatin Combination Regimen.
Topics: Anorexia; Antiemetics; Aprepitant; Carboplatin; Dexamethasone; Female; Granisetron; Humans; Nausea; Neoplasms; Paclitaxel; Palonosetron; Retrospective Studies; Vomiting | 2022 |
Efficacy, Safety And Feasibility Of Antiemetic Prophylaxis With Fosaprepitant, Granisetron And Dexamethasone In Pediatric Patients With Hemato-Oncological Malignancies.
Topics: Adolescent; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cohort Studies; Dexamethasone; Drug Therapy, Combination; Female; Granisetron; Humans; Male; Morpholines; Nausea; Vomiting | 2019 |
Extrapolation of Adult Efficacy to Pediatric Patients With Chemotherapy-Induced Nausea and Vomiting.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antiemetics; Antineoplastic Agents; Aprepitant; Child; Child, Preschool; Clinical Trials as Topic; Data Interpretation, Statistical; Dose-Response Relationship, Drug; Drug Dosage Calculations; Female; Granisetron; Humans; Infant; Male; Middle Aged; Nausea; Neurokinin-1 Receptor Antagonists; Ondansetron; Palonosetron; Treatment Outcome; United States; United States Food and Drug Administration; Vomiting; Young Adult | 2020 |
Antiemetic prophylaxis with fosaprepitant and granisetron in pediatric patients undergoing allogeneic hematopoietic stem cell transplantation.
Topics: Adolescent; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Female; Granisetron; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Infant; Male; Morpholines; Nausea; Transplantation Conditioning; Vomiting | 2020 |
Adherence to ASCO for Prophylaxis of Acute Chemotherapy- Induced Nausea and Vomiting in Iran.
Topics: Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Aprepitant; Drug-Related Side Effects and Adverse Reactions; Female; Follow-Up Studies; Granisetron; Guideline Adherence; Humans; Induction Chemotherapy; Male; Middle Aged; Nausea; Neoplasms; Prognosis; Vomiting | 2020 |
Comparison of two different intravenous serotonin antagonists used for chemotherapy-induced nausea and vomiting prophylaxis in patients treated with moderately emetogenic risk regimens: A retrospective analysis from a large academic medical center.
Topics: Academic Medical Centers; Administration, Intravenous; Adult; Aged; Aged, 80 and over; Antiemetics; Antineoplastic Agents; Female; Granisetron; Humans; Male; Middle Aged; Nausea; Neoplasms; Palonosetron; Retrospective Studies; Serotonin 5-HT3 Receptor Antagonists; Vomiting; Young Adult | 2020 |
Granisetron transdermal system and dexamethasone for the prevention of nausea and vomiting in multiple myeloma patients receiving chemo-mobilization: An observational real-world study of effectiveness and safety.
Topics: Administration, Cutaneous; Adolescent; Adult; Aged; Dexamethasone; Female; Granisetron; Humans; Male; Middle Aged; Multiple Myeloma; Nausea; Prospective Studies; Vomiting; Young Adult | 2020 |
Effects of Palonosetron on Nausea and Vomiting Induced by Multiple-Day Chemotherapy: A Retrospective Study.
Topics: Adult; Antiemetics; Antineoplastic Agents; Benzimidazoles; Bleomycin; Drug Therapy, Combination; Etoposide; Female; Granisetron; Humans; Male; Middle Aged; Nausea; Neoplasms, Germ Cell and Embryonal; Ovarian Neoplasms; Palonosetron; Platinum Compounds; Retrospective Studies; Serotonin 5-HT3 Receptor Antagonists; Testicular Neoplasms; Vomiting | 2021 |
Effects of 5-HT
Topics: Acute Kidney Injury; Aged; Animals; Benzimidazoles; Cisplatin; Disease Models, Animal; Female; Granisetron; Humans; Kidney; Male; Mice; Middle Aged; Nausea; Ondansetron; Organic Cation Transport Proteins; Palonosetron; Renal Elimination; Retrospective Studies; Serotonin 5-HT3 Receptor Antagonists; Vomiting | 2021 |
Granisetron transdermal delivery system is effective in the control of chemotherapy-induced nausea and vomiting in patients receiving moderately emetogenic chemotherapy (MEC) or highly emetogenic chemotherapy (HEC) in China.
Topics: Antiemetics; China; Granisetron; Humans; Nausea; Vomiting | 2017 |
Nausea and vomiting: Therapeutic orphans of pediatric oncology.
Topics: Antiemetics; Child; Child, Preschool; Granisetron; Humans; Methotrexate; Nausea; Ondansetron; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Serotonin 5-HT3 Receptor Antagonists; Vomiting | 2017 |
Clinical Impact of Aprepitant in Patients Receiving High-Dose Chemotherapy prior to Autologous Peripheral Blood Stem Cell Transplantation: A Cost-Effectiveness Analysis.
Topics: Adult; Aged; Antineoplastic Agents; Aprepitant; Cost-Benefit Analysis; Female; Granisetron; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Morpholines; Multiple Myeloma; Nausea; Peripheral Blood Stem Cell Transplantation; Retrospective Studies; Vomiting | 2017 |
Comparison between Antiemetic Effects of Palonosetron and Granisetron on Chemotherapy-Induced Nausea and Vomiting in Japanese Patients Treated with R-CHOP.
Topics: Adult; Aged; Aging; Antibodies, Monoclonal, Murine-Derived; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Asian People; Cyclophosphamide; Doxorubicin; Female; Granisetron; Humans; Isoquinolines; Lymphoma, Non-Hodgkin; Male; Middle Aged; Nausea; Palonosetron; Prednisone; Quinuclidines; Risk Factors; Rituximab; Sex Characteristics; Treatment Outcome; Vincristine; Vomiting; Young Adult | 2017 |
Genetic risk factors for chemotherapy-induced nausea and vomiting in patients with cancer receiving cisplatin-based chemotherapy.
Topics: Adult; Aged; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Clinical Trials, Phase III as Topic; Dexamethasone; Female; Genetic Predisposition to Disease; Granisetron; Humans; Male; Middle Aged; Nausea; Neoplasms; Palonosetron; Polymorphism, Single Nucleotide; Randomized Controlled Trials as Topic; Vomiting | 2018 |
Hydration requirements with emetogenic chemotherapy: granisetron extended-release subcutaneous versus palonosetron.
Topics: Adult; Aged; Aged, 80 and over; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Delayed-Action Preparations; Dexamethasone; Female; Fluid Therapy; Granisetron; Humans; Injections, Subcutaneous; Isoquinolines; Male; Middle Aged; Nausea; Neoplasms; Palonosetron; Practice Guidelines as Topic; Quinuclidines; Retrospective Studies; Serotonin Antagonists; Treatment Outcome; Vomiting | 2018 |
Comparison of antiemetic effects of granisetron and palonosetron in patients receiving bendamustine-based chemotherapy.
Topics: Aged; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Aprepitant; Bendamustine Hydrochloride; Dexamethasone; Female; Granisetron; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Nausea; Palonosetron; Retrospective Studies; Vomiting | 2018 |
Impact of adjuvant lorazepam with granisetron on chemotherapy-induced nausea and vomiting in pediatric patients with acute lymphoblastic leukemia.
Topics: Adjuvants, Pharmaceutic; Adolescent; Adrenal Cortex Hormones; Anthracyclines; Antiemetics; Antineoplastic Agents; Child; Child, Preschool; Drug Therapy, Combination; Female; Granisetron; Humans; Induction Chemotherapy; Infant; Lorazepam; Male; Nausea; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Quality of Life; Retrospective Studies; Risk Factors; Vomiting | 2019 |
Hydration requirements in patients receiving highly emetogenic chemotherapy.
Topics: Adult; Aged; Aged, 80 and over; Antiemetics; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Delayed-Action Preparations; Dexamethasone; Female; Fluid Therapy; Granisetron; Humans; Male; Middle Aged; Morpholines; Nausea; Neoplasms; Neurokinin-1 Receptor Antagonists; Palonosetron; Retrospective Studies; Serotonin 5-HT3 Receptor Antagonists; Vomiting; Young Adult | 2019 |
[Management of nausea and vomiting in cancer patients. Use of transdermal patches containing granisetron in patients affected by head and neck squamous-cell carcinoma].
Topics: Antiemetics; Antineoplastic Agents; Granisetron; Head and Neck Neoplasms; Humans; Male; Middle Aged; Nausea; Quality of Life; Squamous Cell Carcinoma of Head and Neck; Transdermal Patch; Vomiting | 2018 |
Comparison of palonosetron and granisetron in triplet antiemetic therapy in nonmetastatic breast cancer patients receiving high emetogenic chemotherapy: a multicenter, prospective, and observational study.
Topics: Adult; Aged; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Aprepitant; Breast Neoplasms; Cyclophosphamide; Dexamethasone; Doxorubicin; Drug Therapy, Combination; Epirubicin; Female; Granisetron; Humans; Middle Aged; Nausea; Palonosetron; Prospective Studies; Vomiting | 2019 |
[Out-patient management of nausea and vomiting in multiday therapy of acute myeloid leukemia in the elderly. Use of granisetron in slow-release transdermal formulation. Clinical case].
Topics: Ambulatory Care; Antiemetics; Antineoplastic Agents; Delayed-Action Preparations; Female; Granisetron; Humans; Leukemia, Myeloid, Acute; Middle Aged; Nausea; Quality of Life; Vomiting | 2019 |
Cost-effectiveness of a fixed combination of netupitant and palonosetron (NEPA) relative to aprepitant plus granisetron (APR + GRAN) for prophylaxis of chemotherapy-induced nausea and vomiting (CINV): a trial-based analysis.
Topics: Antiemetics; Aprepitant; Cost-Benefit Analysis; Drug Therapy, Combination; Female; Granisetron; Humans; Male; Middle Aged; Nausea; Palonosetron; Pyridines; Vomiting | 2020 |
Effectiveness and safety of antiemetic aprepitant in Japanese patients receiving high-dose chemotherapy prior to autologous hematopoietic stem cell transplantation.
Topics: Adult; Aged; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Aprepitant; Asian People; Female; Granisetron; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Male; Middle Aged; Morpholines; Nausea; Neurokinin-1 Receptor Antagonists; Retrospective Studies; Treatment Outcome; Vomiting; Young Adult | 2013 |
Efficacy and safety of aprepitant in allogeneic hematopoietic stem cell transplantation.
Topics: Adult; Aged; Antiemetics; Antineoplastic Agents; Aprepitant; Drug Therapy, Combination; Female; Granisetron; Hematopoietic Stem Cell Transplantation; Humans; Male; Middle Aged; Morpholines; Nausea; Retrospective Studies; Transplantation, Homologous; Vomiting | 2013 |
[Comparison of antiemesis effects of granisetron, aprepitant and dexamethasone to palonosetron, aprepitant and dexamethasone in treatment of high-emetic risk chemotherapy-induced nausea and vomiting - a retrospective study for efficacy and safety in a sin
Topics: Aged; Antiemetics; Antineoplastic Agents; Aprepitant; Dexamethasone; Drug Combinations; Female; Granisetron; Humans; Isoquinolines; Male; Middle Aged; Morpholines; Nausea; Neoplasms; Palonosetron; Quinuclidines; Retrospective Studies; Risk; Vomiting | 2013 |
Evaluation of the relation between patient characteristics and the state of chemotherapy-induced nausea and vomiting in patients with gynecologic cancer receiving paclitaxel and carboplatin.
Topics: Adult; Aged; Aged, 80 and over; Antiemetics; Antineoplastic Agents; Carboplatin; Dexamethasone; Female; Genital Neoplasms, Female; Granisetron; Humans; Hyperemesis Gravidarum; Hypertension; Middle Aged; Multivariate Analysis; Nausea; Paclitaxel; Pregnancy; Retrospective Studies; Surveys and Questionnaires; Vomiting | 2014 |
[Anti-emetic effect of granisetron in patients undergoing cranial and craniospinal radiotherapy].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antiemetics; Child; Child, Preschool; Female; Granisetron; Head and Neck Neoplasms; Humans; Male; Middle Aged; Nausea; Nervous System Neoplasms; Radiotherapy; Vomiting; Young Adult | 2014 |
Cost-effectiveness analysis of granisetron-based versus standard antiemetic regimens in low-emetogenic chemotherapy: a hospital-based perspective from Malaysia.
Topics: Antiemetics; Antineoplastic Agents; Cost-Benefit Analysis; Dexamethasone; Drug Therapy, Combination; Follow-Up Studies; Granisetron; Humans; Malaysia; Metoclopramide; Nausea; Neoplasms; Prognosis; Retrospective Studies; Vomiting | 2013 |
Theoretical evaluation of antiemetic effects of 5-HT3 receptor antagonists for prevention of vomiting induced by cisplatin.
Topics: Antineoplastic Agents; Bridged Bicyclo Compounds, Heterocyclic; Cisplatin; Constipation; Creatinine; Granisetron; Humans; Hydroxyindoleacetic Acid; Intestine, Small; Isoquinolines; Models, Biological; Nausea; Oxazines; Palonosetron; Quinuclidines; Receptors, Serotonin, 5-HT3; Serotonin; Serotonin 5-HT3 Receptor Antagonists; Vomiting | 2015 |
Involvement of substance P in the development of cisplatin-induced acute and delayed pica in rats.
Topics: Animals; Antiemetics; Antineoplastic Agents; Aprepitant; Cisplatin; Eating; Granisetron; Kaolin; Male; Medulla Oblongata; Morpholines; Nausea; Neurokinin-1 Receptor Antagonists; Pica; Protein Precursors; Rats, Wistar; Receptors, Neurokinin-1; Receptors, Serotonin, 5-HT3; RNA, Messenger; Serotonin Antagonists; Solitary Nucleus; Substance P; Tachykinins | 2014 |
Efficacy of aprepitant for nausea in patients with head and neck cancer receiving daily cisplatin therapy.
Topics: Antiemetics; Antineoplastic Agents; Aprepitant; Cisplatin; Dexamethasone; Drug Therapy, Combination; Fluorouracil; Granisetron; Head and Neck Neoplasms; Humans; Morpholines; Nausea; Neurokinin-1 Receptor Antagonists; Prospective Studies; Treatment Outcome; Vomiting | 2014 |
Efficacy of granisetron and aprepitant in a patient who failed ondansetron in the prophylaxis of radiation induced nausea and vomiting: a case report.
Topics: Antiemetics; Aprepitant; Bone Neoplasms; Breast Neoplasms; Female; Granisetron; Humans; Middle Aged; Morpholines; Nausea; Neoplasm Metastasis; Ondansetron | 2015 |
Preclinical evaluation of dual action intranasal formulation intended for postoperative/cancer associated therapies.
Topics: Adhesiveness; Administration, Inhalation; Administration, Oral; Analgesics; Animals; Anti-Inflammatory Agents, Non-Steroidal; Antiemetics; Antineoplastic Agents; Chemistry, Pharmaceutical; Disease Models, Animal; Drug Carriers; Excipients; Gels; Granisetron; Hydrogen-Ion Concentration; Ketorolac Tromethamine; Kinetics; Mucociliary Clearance; Nausea; Nociception; Pain, Postoperative; Polymers; Postoperative Nausea and Vomiting; Solubility; Spectrophotometry, Infrared; Technology, Pharmaceutical; Temperature; Viscosity; Vomiting | 2015 |
Palonosetron with aprepitant plus dexamethasone to prevent chemotherapy-induced nausea and vomiting during gemcitabine/cisplatin in urothelial cancer patients.
Topics: Adult; Aged; Aged, 80 and over; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Aprepitant; Carcinoma, Transitional Cell; Cisplatin; Deoxycytidine; Dexamethasone; Drug Therapy, Combination; Female; Gemcitabine; Granisetron; Humans; Isoquinolines; Kidney Neoplasms; Male; Middle Aged; Morpholines; Nausea; Ondansetron; Palonosetron; Quinuclidines; Retrospective Studies; Serotonin 5-HT3 Receptor Antagonists; Serotonin Antagonists; Ureteral Neoplasms; Urinary Bladder Neoplasms; Urologic Neoplasms; Vomiting | 2015 |
Induction and antagonism of pica induced by teriparatide in rats.
Topics: Age Factors; Animals; Anorexia; Antiemetics; Diphenhydramine; Disease Models, Animal; Dopamine D2 Receptor Antagonists; Dose-Response Relationship, Drug; Eating; Feeding Behavior; Female; Granisetron; Histamine H1 Antagonists; Kaolin; Male; Morpholines; Nausea; Neurokinin-1 Receptor Antagonists; Neurotransmitter Agents; Ovariectomy; Pica; Prochlorperazine; Rats, Wistar; Serotonin 5-HT3 Receptor Antagonists; Teriparatide | 2015 |
Evaluation of the efficacy of palonosetron for prevention of chemotherapy-induced nausea and vomiting in patients with gastric cancer treated with S-1 plus cisplatin.
Topics: Aged; Aged, 80 and over; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Aprepitant; Cisplatin; Dexamethasone; Drug Combinations; Drug Therapy, Combination; Female; Granisetron; Humans; Isoquinolines; Male; Middle Aged; Morpholines; Nausea; Oxonic Acid; Palonosetron; Prospective Studies; Quality of Life; Quinuclidines; Stomach Neoplasms; Surveys and Questionnaires; Tegafur; Vomiting | 2016 |
Exploration of Antiemetics for Osteoporosis Therapy-Induced Nausea and Vomiting Using PET Molecular Imaging Analysis to Gastrointestinal Pharmacokinetics.
Topics: Animals; Antiemetics; Benzamides; Bone Density Conservation Agents; Caco-2 Cells; Gastrointestinal Absorption; Gastrointestinal Motility; Gastrointestinal Tract; Granisetron; Humans; Male; Morpholines; Nausea; Osteoporosis; Positron-Emission Tomography; Rats; Rats, Sprague-Dawley; Teriparatide; Vomiting | 2016 |
Evaluation of Antiemetic Therapy for Hepatic Transcatheter Arterial Infusion Chemotherapy with Cisplatin.
Topics: Adult; Aged; Aged, 80 and over; Antiemetics; Antineoplastic Agents; Aprepitant; Bridged Bicyclo Compounds, Heterocyclic; Catheterization, Peripheral; Cisplatin; Dexamethasone; Drug Therapy, Combination; Female; Granisetron; Humans; Isoquinolines; Liver; Liver Neoplasms; Male; Middle Aged; Morpholines; Nausea; Oxazines; Palonosetron; Quinuclidines; Serotonin 5-HT3 Receptor Antagonists; Vomiting | 2016 |
Economic evaluation of 5-HT3 receptor antagonists in combination with dexamethasone for the prevention of 'overall' nausea and vomiting following highly emetogenic chemotherapy in Chinese adult patients.
Topics: Adult; Antiemetics; Antineoplastic Agents; Asian People; Clinical Trials, Phase III as Topic; Cost-Benefit Analysis; Dexamethasone; Granisetron; Humans; Isoquinolines; Nausea; Ondansetron; Palonosetron; Quinuclidines; Randomized Controlled Trials as Topic; Receptors, Serotonin, 5-HT3; Vomiting | 2017 |
Transdermal patch tailors antinausea treatment.
Topics: Administration, Cutaneous; Antiemetics; Antineoplastic Agents; Clinical Trials, Phase III as Topic; Drug Therapy, Combination; Granisetron; Humans; Managed Care Programs; Medical Oncology; Nausea; Neoplasms; Neurokinin-1 Receptor Antagonists; Premedication; Serotonin 5-HT2 Receptor Antagonists | 2008 |
Granisetron transdermal system: a new option to help prevent chemotherapy-induced nausea and vomiting.
Topics: Administration, Cutaneous; Antiemetics; Antineoplastic Agents; Granisetron; Humans; Nausea; Neoplasms; Serotonin Antagonists; Vomiting | 2009 |
Transdermal medication delivery helps prevent CINV.
Topics: Administration, Cutaneous; Antiemetics; Granisetron; Humans; Nausea; Patient Education as Topic; Serotonin Antagonists; Vomiting | 2010 |
Anaphylactic reaction owing to ondansetron administration in a child with neuroblastoma and safe use of granisetron: a case report.
Topics: Anaphylaxis; Antiemetics; Antineoplastic Agents; Brain Neoplasms; Female; Granisetron; Humans; Infant; Nausea; Neuroblastoma; Ondansetron; Vomiting | 2010 |
Genetic polymorphisms in the three malaysian races effect granisetron clinical antiemetic actions in breast cancer patients receiving chemotherapy.
Topics: Adult; Aged; Antiemetics; Antineoplastic Agents; Breast Neoplasms; Cytochrome P-450 CYP3A; Female; Follow-Up Studies; Granisetron; Humans; Longitudinal Studies; Malaysia; Middle Aged; Nausea; Neoplasm Staging; Polymorphism, Genetic; Prospective Studies; Serotonin 5-HT3 Receptor Antagonists; Vomiting | 2011 |
[Comparison of 1 mg/body and 3 mg/body of intravenous granisetron for the prevention of chemotherapy-induced nausea and vomiting and adverse events in hematological malignancy patients].
Topics: Adult; Aged; Aged, 80 and over; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Constipation; Dose-Response Relationship, Drug; Female; Granisetron; Hematologic Neoplasms; Humans; Infusions, Intravenous; Male; Middle Aged; Nausea; Retrospective Studies; Serotonin Antagonists; Vomiting | 2012 |
Transdermal granisetron: a guide to its use in preventing nausea and vomiting induced by chemotherapy.
Topics: Administration, Cutaneous; Antiemetics; Antineoplastic Agents; Clinical Trials, Phase III as Topic; Granisetron; Humans; Multicenter Studies as Topic; Nausea; Practice Guidelines as Topic; Randomized Controlled Trials as Topic; Treatment Outcome; Vomiting | 2012 |
[Efficacy of granisetron for preventing chemotherapy-induced nausea and vomiting in patients with acute myelogenous leukemia treated with a combination of anthracycline and cytarabine].
Topics: Adult; Aged; Aged, 80 and over; Anthracyclines; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Constipation; Cytarabine; Female; Granisetron; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Nausea; Retrospective Studies; Vomiting; Young Adult | 2012 |
Is there an association between PONV and chemotherapy-induced nausea and vomiting?
Topics: Adult; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Betamethasone; Breast Neoplasms; Chemotherapy, Adjuvant; Combined Modality Therapy; Cyclophosphamide; Disease Resistance; Droperidol; Epirubicin; Female; Fluorouracil; Granisetron; Humans; Mastectomy; Methotrexate; Metoclopramide; Middle Aged; Models, Biological; Narcotics; Nausea; Ondansetron; Postoperative Nausea and Vomiting; Prospective Studies; Risk Factors; Vomiting | 2013 |
Aprepitant plus granisetron and dexamethasone for prevention of chemotherapy-induced nausea and vomiting in patients with gastric cancer treated with S-1 plus cisplatin.
Topics: Aged; Aged, 80 and over; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Aprepitant; Cisplatin; Dexamethasone; Drug Combinations; Drug Therapy, Combination; Female; Granisetron; Humans; Male; Middle Aged; Morpholines; Nausea; Neoplasm Staging; Oxonic Acid; Prospective Studies; Psychometrics; Quality of Life; Stomach Neoplasms; Tegafur; Treatment Outcome; Vomiting | 2013 |
Antiemetic effectiveness and safety of aprepitant in patients with hematologic malignancy receiving multiday chemotherapy.
Topics: Administration, Oral; Adult; Aged; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Aprepitant; Drug Therapy, Combination; Female; Granisetron; Hematologic Neoplasms; Hospitals, University; Humans; Male; Middle Aged; Morpholines; Nausea; Retrospective Studies; Treatment Outcome; Vomiting; Young Adult | 2013 |
Effects of lerisetron, a new 5-HT3 receptor antagonist, on ipecacuanha-induced emesis in healthy volunteers.
Topics: Administration, Oral; Adolescent; Adult; Antiemetics; Benzimidazoles; Dose-Response Relationship, Drug; Emetics; Granisetron; Humans; Injections, Intravenous; Ipecac; Male; Nausea; Piperidines; Receptors, Serotonin; Receptors, Serotonin, 5-HT3; Serotonin Antagonists; Time Factors; Vomiting | 2002 |
Patient outcomes after therapeutic interchange of dolasetron for granisetron.
Topics: Adult; Aged; Aged, 80 and over; Antiemetics; Antineoplastic Agents; Cohort Studies; Female; Granisetron; Humans; Indoles; Male; Middle Aged; Nausea; Quinolizines; Therapeutic Equivalency; Treatment Outcome; United States; Vomiting | 2003 |
Low-dose granisetron for prophylaxis of acute chemotherapy-induced nausea and vomiting: a pilot study.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brazil; Female; Granisetron; Humans; Male; Middle Aged; Nausea; Neoplasms; Pilot Projects; Serotonin Antagonists; Surveys and Questionnaires; Vomiting | 2005 |
5HT3-receptor antagonists as antiemetics in cancer.
Topics: Adult; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Child; Granisetron; Humans; Indoles; Isoquinolines; Nausea; Neoplasms; Ondansetron; Palonosetron; Practice Guidelines as Topic; Quinolizines; Quinuclidines; Serotonin 5-HT3 Receptor Antagonists; Serotonin Antagonists; Tropisetron; Vomiting | 2005 |
Biochronomer technology.
Topics: Anesthetics, Local; Chemistry, Pharmaceutical; Clinical Trials as Topic; Delayed-Action Preparations; Drug Delivery Systems; Gels; Granisetron; Humans; Hydrolysis; Mepivacaine; Nausea; Pain, Postoperative; Polyanhydrides; Polyesters; Polymers; Serotonin Antagonists; Solubility; Surface Properties; Time Factors; Vaccines, DNA | 2005 |
Re: The effects of ondansetron and granisetron on electrocardiography in children receiving chemotherapy for acute leukemia.
Topics: Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Child; Electrocardiography; Granisetron; Heart Rate; Humans; Nausea; Ondansetron; Precursor Cell Lymphoblastic Leukemia-Lymphoma | 2005 |
[Relationship between neurotransmitter blood noradrenalin and nausea/emesis after chemotherapy for lung cancer].
Topics: Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Catecholamines; Cisplatin; Docetaxel; Drug Administration Schedule; Drug Therapy, Combination; Granisetron; Humans; Lung Neoplasms; Methylprednisolone; Metoclopramide; Nausea; Neurotransmitter Agents; Norepinephrine; Serotonin; Taxoids; Vomiting, Anticipatory | 2006 |
Relative efficacy of ondansetron, granisetron, dolasetron and palonosetron in controlling acute nausea and vomiting associated with platinum-based chemotherapy.
Topics: Antiemetics; Granisetron; Humans; Indoles; Isoquinolines; Nausea; Ondansetron; Organoplatinum Compounds; Palonosetron; Quinolizines; Quinuclidines; Treatment Outcome; Vomiting | 2006 |
[Comparison of antiemetic efficacy of 5-HT3 receptor antagonists in orthopedics cancer patients receiving high-dose chemotherapy].
Topics: Adolescent; Adult; Aged; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Benzimidazoles; Bone Neoplasms; Cisplatin; Dose-Response Relationship, Drug; Doxorubicin; Drug Administration Schedule; Female; Granisetron; Humans; Ifosfamide; Male; Middle Aged; Nausea; Ondansetron; Osteosarcoma; Prospective Studies; Serotonin 5-HT3 Receptor Antagonists; Vomiting | 2007 |
Antiemetic agents.
Topics: Administration, Oral; Anorexia; Antiemetics; Antineoplastic Agents; Aprepitant; Asthenia; Constipation; Diarrhea; Drug Interactions; Dyspepsia; Fatigue; Fever; Granisetron; Headache; Hiccup; Humans; Indoles; Injections, Intravenous; Isoquinolines; Morpholines; Nausea; Neoplasms; Ondansetron; Palonosetron; Quinolizines; Quinuclidines; Vomiting | 2007 |
Management of platinum-based chemotherapy-induced acute nausea and vomiting: is there a superior serotonin receptor antagonist?
Topics: Acute Disease; Adolescent; Adult; Aged; Aged, 80 and over; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Dexamethasone; Female; Granisetron; Humans; Indoles; Male; Middle Aged; Nausea; Neoplasms; Ondansetron; Platinum Compounds; Quinolizines; Retrospective Studies; Serotonin 5-HT3 Receptor Antagonists; Vomiting | 2007 |
Intractable nausea and vomiting successfully related with granisetron 5-hydroxytryptamine type 3 receptor antagonists in Palliative Medicine.
Topics: Antiemetics; Breast Neoplasms; Female; Granisetron; Humans; Middle Aged; Nausea; Ovarian Neoplasms; Palliative Care; Treatment Outcome; Vomiting | 2007 |
[Clinical evaluation of antiemetic effects of 5-hydroxytryptamine receptor type 3 (5HT3 receptor) antagonists based on changes in eating condition in cancer patients receiving chemotherapy].
Topics: Adult; Aged; Aged, 80 and over; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Benzimidazoles; Bridged Bicyclo Compounds, Heterocyclic; Eating; Female; Granisetron; Humans; Male; Middle Aged; Nausea; Neoplasms; Oxazines; Serotonin 5-HT3 Receptor Antagonists; Serotonin Antagonists; Treatment Outcome; Vomiting | 2008 |
[Effective measures against side effects by increasing ACNU dose for malignant glioma: effects on digestive organs].
Topics: Adult; Aged; Anorexia; Brain Neoplasms; Drug Therapy, Combination; Female; Glioma; Granisetron; Granulocyte Colony-Stimulating Factor; Humans; Male; Middle Aged; Nausea; Nimustine; Vomiting | 1994 |
Overview: oral granisetron (Kytril tablets) prophylaxis for chemotherapy-induced nausea and vomiting.
Topics: Administration, Oral; Antiemetics; Antineoplastic Agents; Granisetron; Humans; Nausea; Serotonin Antagonists; Vomiting | 1995 |
[Efficacy of the granisetron/solumedrol combination in the control of drug-induced acute nausea and vomiting. Results of a prospective survey].
Topics: Antiemetics; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Bronchial Neoplasms; Drug Therapy, Combination; Female; Granisetron; Health Surveys; Humans; Male; Methylprednisolone Hemisuccinate; Middle Aged; Nausea; Prospective Studies; Serotonin Receptor Agonists; Vomiting | 1995 |
The piglet as a suitable animal model for studying the delayed phase of cisplatin-induced emesis.
Topics: Animals; Cisplatin; Disease Models, Animal; Female; Granisetron; Male; Nausea; Ondansetron; Swine; Time Factors; Vomiting | 1995 |
[The efficacy of granisetron as a prophylactic anti-emetic agent used in conjunction with MCNU and VP16 chemotherapeutic regimens in the management of a pediatric case of hypothalamic anaplastic astrocytoma].
Topics: Antineoplastic Combined Chemotherapy Protocols; Child; Combined Modality Therapy; Etoposide; Glioblastoma; Granisetron; Humans; Hypothalamic Neoplasms; Interferon-beta; Male; Nausea; Nitrosourea Compounds; Vomiting | 1995 |
Antiemetic properties of granisetron.
Topics: Costs and Cost Analysis; Granisetron; Humans; Nausea; Vomiting | 1995 |
[Value of granisetron in the prevention of digestive disorders in total body irradiation].
Topics: Adult; Aged; Bone Marrow Transplantation; Combined Modality Therapy; Female; Granisetron; Humans; Lymphoproliferative Disorders; Male; Middle Aged; Nausea; Radiotherapy Dosage; Treatment Outcome; Vomiting; Whole-Body Irradiation | 1994 |
Granisetron enters antiemetic market.
Topics: Antineoplastic Agents; Granisetron; Humans; Nausea; Product Surveillance, Postmarketing; Vomiting | 1994 |
Further studies of the antiemetic activity of granisetron against whole body X-irradiation or cisplatin-induced emesis in the ferret.
Topics: Animals; Cisplatin; Dose-Response Relationship, Drug; Female; Ferrets; Granisetron; Male; Nausea; Premedication; Vomiting; Whole-Body Irradiation | 1994 |
The incidence of anticipatory nausea and vomiting after repeat cycle chemotherapy: the effect of granisetron.
Topics: Female; Granisetron; Humans; Longitudinal Studies; Male; Nausea; Retrospective Studies; Vomiting, Anticipatory | 1994 |
Repeated use of granisetron in patients receiving cytostatic agents.
Topics: Adult; Age Factors; Aged; Antiemetics; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Constipation; Female; Granisetron; Headache; Humans; Indazoles; Infusions, Intravenous; Male; Middle Aged; Nausea; Remission Induction; Serotonin Antagonists; Vomiting | 1993 |
[The prevention of CDDP-induced emesis with granisetron].
Topics: Antiemetics; Cisplatin; Female; Granisetron; Humans; Indazoles; Infusions, Intravenous; Nausea; Ovarian Neoplasms; Uterine Neoplasms; Vomiting | 1993 |
[Antiemetic efficacy of granisetron in patients receiving 5-day continuous infusion of cisplatin].
Topics: Adenocarcinoma; Aged; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Cisplatin; Drug Administration Schedule; Etoposide; Female; Granisetron; Humans; Indazoles; Infusions, Intra-Arterial; Lung Neoplasms; Male; Middle Aged; Nausea; Vindesine; Vomiting | 1993 |
Granisetron (Kytril): a survey of use in clinical practice in Switzerland.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antiemetics; Antineoplastic Agents; Drug Utilization; Drug Utilization Review; Female; Granisetron; Humans; Male; Medical Oncology; Middle Aged; Nausea; Practice Patterns, Physicians'; Product Surveillance, Postmarketing; Surveys and Questionnaires; Switzerland; Vomiting | 1995 |
Re: 'Cost-effectiveness of 5-hydroxytryptamin3 receptor antagonists: a retrospective comparison of ondansetron and granisetron'.
Topics: Cost-Benefit Analysis; Granisetron; Nausea; Ondansetron; Salvage Therapy; Serotonin Antagonists; Vomiting | 1996 |
Expanded use of oral granisetron.
Topics: Administration, Oral; Antiemetics; Bone Marrow Transplantation; Granisetron; Humans; Injections, Intravenous; Nausea; Vomiting | 1996 |
Tardive dyskinesia as a result of long-term prochlorperazine use.
Topics: Antiemetics; Dopamine Antagonists; Dyskinesia, Drug-Induced; Fatal Outcome; Female; Granisetron; Humans; Middle Aged; Nausea; Ondansetron; Prochlorperazine; Time Factors; Vomiting | 1996 |
Always more "setrons": how many do we need?
Topics: Antiemetics; Antineoplastic Agents; Drug Costs; Granisetron; Humans; Indoles; Nausea; Ondansetron; Serotonin Antagonists; Tropisetron; Vomiting | 1997 |
[Antiemetic efficacy of granisetron in repeated CAF chemotherapy after breast cancer operation].
Topics: Adult; Aged; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Female; Fluorouracil; Granisetron; Humans; Middle Aged; Nausea; Postoperative Period; Vomiting | 1997 |
Comparison of intravenous granisetron with metoclopramide plus dexamethasone in the prevention of nausea and vomiting associated with emetogenic cytotoxic chemotherapy.
Topics: Adult; Aged; Antineoplastic Agents; Dexamethasone; Female; Granisetron; Humans; Injections, Intravenous; Male; Metoclopramide; Middle Aged; Nausea; Neoplasms; Vomiting | 1997 |
Fighting nausea in the '90s: more and better anti-emetics can help.
Topics: Antiemetics; Antineoplastic Agents; Dexamethasone; Drug Synergism; Drug Therapy, Combination; Granisetron; Humans; Isonipecotic Acids; Nausea; Ondansetron; Serotonin Antagonists; Substance P; Vomiting | 1997 |
Assuring the optimal use of serotonin antagonist antiemetics: the process for development and implementation of institutional antiemetic guidelines at Memorial Sloan-Kettering Cancer Center.
Topics: Antiemetics; Antineoplastic Agents; Dexamethasone; Drug Utilization; Female; Granisetron; Guideline Adherence; Humans; Male; Nausea; Ondansetron; Practice Guidelines as Topic; Quality Assurance, Health Care; Serotonin Antagonists; Vomiting | 1998 |
Anti-emetic effect of ondansetron and granisetron after exposure to mixed neutron and gamma irradiation.
Topics: Animals; Antiemetics; Gamma Rays; Granisetron; Macaca fascicularis; Male; Nausea; Neutrons; Ondansetron; Radiation Injuries, Experimental; Receptors, Serotonin; Receptors, Serotonin, 5-HT3; Serotonin Antagonists; Vomiting | 1998 |
[Therapeutic potential of Granisetron (Kitryl) for the prevention of nausea and vomiting induced by cytostatic drugs].
Topics: Administration, Oral; Adult; Aged; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Female; Granisetron; Humans; Male; Middle Aged; Nausea; Treatment Outcome; Vomiting | 1998 |
Inappropriate use of placebo.
Topics: Antiemetics; Ear, Middle; Granisetron; Humans; Nausea; Placebos; Postoperative Complications; Vomiting | 1998 |
The antiemetic efficacy of granisetron plus dexamethasone, haloperidol and loracepam in breast cancer patients treated with high-dose chemotherapy with peripheral blood stem-cell support.
Topics: Adult; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Dexamethasone; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; Granisetron; Haloperidol; Hematopoietic Stem Cell Transplantation; Humans; Lorazepam; Middle Aged; Nausea; Palliative Care; Treatment Outcome; Vomiting | 1998 |
Outcomes of antiemetic therapy after the administration of high-dose antineoplastic agents.
Topics: Adult; Aged; Antiemetics; Antineoplastic Agents; Dexamethasone; Drug Therapy, Combination; Female; Granisetron; Humans; Male; Middle Aged; Nausea; Neoplasms; Retrospective Studies; Severity of Illness Index; Treatment Outcome; Vomiting | 1998 |
Initial high anti-emetic efficacy of granisetron with dexamethasone is not maintained over repeated cycles.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antiemetics; Antineoplastic Agents; Cisplatin; Dexamethasone; Female; Granisetron; Humans; Male; Middle Aged; Nausea; Neoplasms; Serotonin Antagonists; Vomiting | 1998 |
Stability of granisetron hydrochloride in two oral suspensions.
Topics: Administration, Oral; Antiemetics; Chromatography, High Pressure Liquid; Drug Compounding; Drug Stability; Granisetron; Humans; Nausea | 1998 |
Economics of serotonin 5-HT3 antagonists.
Topics: Drug-Related Side Effects and Adverse Reactions; Granisetron; Humans; Nausea; Receptors, Serotonin; Receptors, Serotonin, 5-HT3; Serotonin Antagonists; Vomiting | 1996 |
Neurokinin antagonism and chemotherapy-induced emesis.
Topics: Acetals; Antiemetics; Antineoplastic Agents; Aprepitant; Cisplatin; Dexamethasone; Female; Granisetron; Humans; Male; Morpholines; Multicenter Studies as Topic; Nausea; Neurokinin-1 Receptor Antagonists; Randomized Controlled Trials as Topic; Substance P; Vomiting | 1999 |
Manifest Anxiety Scale for evaluation of effects of granisetron in chemotherapy with CDDP and 5FU for head and neck cancer.
Topics: Adult; Aged; Antiemetics; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Anxiety; Carcinoma, Squamous Cell; Cisplatin; Drug Administration Schedule; Evaluation Studies as Topic; Female; Fluorouracil; Granisetron; Head and Neck Neoplasms; Humans; Male; Manifest Anxiety Scale; Middle Aged; Nausea; Vomiting | 2001 |
Implementing evidence based antiemetic guidelines in the oncology setting: results of a 4-month prospective intervention study.
Topics: Adult; Aged; Antiemetics; Antineoplastic Agents; Cost Control; Drug Costs; Evidence-Based Medicine; Female; Granisetron; Humans; Male; Middle Aged; Nausea; Practice Guidelines as Topic; Prospective Studies; Quality of Health Care; Vomiting | 2001 |
Effectiveness of serotonin-receptor antagonist antiemetic therapy over successive courses of carboplatin-based chemotherapy.
Topics: Adult; Aged; Aged, 80 and over; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Bridged-Ring Compounds; Carboplatin; Clinical Trials as Topic; Dexamethasone; Drug Administration Schedule; Female; Genital Neoplasms, Female; Granisetron; Humans; Middle Aged; Nausea; Ondansetron; Retrospective Studies; Serotonin Antagonists; Taxoids; Vomiting | 2002 |
[Nausea and vomiting in chemotherapy].
Topics: Antineoplastic Agents; Clinical Protocols; Granisetron; Humans; Indazoles; Nausea; Vomiting | 1992 |
Dose granisetron remain effective over multiple cycles? The Granisetron Study Group.
Topics: Adult; Aged; Antiemetics; Antineoplastic Agents; Drug Administration Schedule; Female; Granisetron; Humans; Indazoles; Male; Middle Aged; Nausea; Serotonin Antagonists; Sex Factors; Vomiting | 1992 |
The budgetary impact of 5-HT3 receptor antagonists in the management of chemotherapy-induced emesis.
Topics: Antiemetics; Antineoplastic Agents; Drug Costs; Granisetron; Humans; Indazoles; Models, Theoretical; Nausea; Ondansetron; Serotonin Antagonists; Vomiting | 1992 |
Caring for the cancer patient: managing emesis now. An interactive workshop. Proceedings of a satellite symposium to the 6th European Conference on Clinical Oncology. Florence, October 1991.
Topics: Antiemetics; Antineoplastic Agents; Granisetron; Humans; Indazoles; Nausea; Vomiting | 1992 |
Who should receive a 5-HT3 antagonist?
Topics: Acute Disease; Antineoplastic Agents; Granisetron; Humans; Indazoles; Nausea; Ondansetron; Serotonin Antagonists; Vomiting | 1992 |
Efficacy and safety of granisetron in the prevention of chemotherapy-induced emesis in paediatric patients.
Topics: Adolescent; Antineoplastic Agents; Child; Child, Preschool; Female; Granisetron; Humans; Indazoles; Male; Nausea; Prognosis; Serotonin Antagonists; Time Factors; Vomiting | 1991 |
Phase I/II trial of granisetron: a novel 5-hydroxytryptamine antagonist for the prevention of chemotherapy-induced nausea and vomiting.
Topics: Antiemetics; Antineoplastic Agents; Aspartate Aminotransferases; Chromatography, High Pressure Liquid; Cisplatin; Doxorubicin; Drug Evaluation; Drug Tolerance; Granisetron; Humans; Indazoles; Nausea; Pyrazoles; Serotonin Antagonists; Vomiting | 1990 |
A pharmacokinetic study of granisetron (BRL 43694A), a selective 5-HT3 receptor antagonist: correlation with anti-emetic response.
Topics: Adult; Aged; Antiemetics; Basal Metabolism; Chromatography, High Pressure Liquid; Cisplatin; Female; Granisetron; Half-Life; Humans; Indazoles; Male; Middle Aged; Nausea; Pyrazoles; Serotonin Antagonists | 1989 |
A phase I study of a new 5HT3-receptor antagonist, BRL43694A, an agent for the prevention of chemotherapy-induced nausea and vomiting.
Topics: Adult; Aged; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Drug Evaluation; Drug Tolerance; Female; Granisetron; Humans; Indazoles; Male; Middle Aged; Nausea; Neoplasms; Pyrazoles; Serotonin Antagonists; Vomiting | 1989 |
The serotonin type 3 receptor antagonist BRL 43694 and nausea and vomiting induced by cisplatin.
Topics: Cisplatin; Dose-Response Relationship, Drug; Female; Granisetron; Humans; Indazoles; Male; Nausea; Pyrazoles; Serotonin Antagonists | 1988 |
BRL 43694: a novel antiemetic to prevent nausea and vomiting induced by chemotherapy.
Topics: Adult; Aged; Antiemetics; Antineoplastic Agents; Female; Granisetron; Humans; Indazoles; Male; Middle Aged; Nausea; Pyrazoles; Vomiting | 1988 |